var title_f21_53_22352="Hip effusion plain film";
var content_f21_53_22352=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81582&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plain film left hip effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 307px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The iliopsoas fat pad on the left is bowed and inferiorly displaced (arrows), suggesting effusion. The obturator (medial) and gluteal (superior) fat pads can also be displaced by effusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael Rosenthal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22352=[""].join("\n");
var outline_f21_53_22352=null;
var title_f21_53_22353="Dilated sm bowel NG tube";
var content_f21_53_22353=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81325&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81325&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Small bowel obstruction plain x-ray (supine)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 381px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plain, supine abdominal x-ray showing dilated small bowel. Note a nasogastric tube has passed beyond the pylorus into the duodenum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard A Hodin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22353=[""].join("\n");
var outline_f21_53_22353=null;
var title_f21_53_22354="Sellick maneuver";
var content_f21_53_22354=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F71800&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F71800&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Cricoid pressure (Sellick's maneuver)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 362px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cricoid pressure (Sellick's maneuver). Posterior displacement of the airway cartilages occludes the compliant esophagus. In infants and young children, the tracheal cartilage is also very compliant and excessive force while applying cricoid pressure may impair airway patency.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: King C, Rappaport LD. Emergent endotracheal intubation. In: Textbook of Pediatric Emergency Procedures, 2nd ed, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22354=[""].join("\n");
var outline_f21_53_22354=null;
var title_f21_53_22355="Atropine and pralidoxime: Patient drug information";
var content_f21_53_22355=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Atropine and pralidoxime: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/24/44421?source=see_link\">",
"     see \"Atropine and pralidoxime: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F4302652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      ATNAA;",
"     </li>",
"     <li>",
"      Duodote&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691561",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to avoid side effects from nerve gas or chemicals that kill insects.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701571",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to atropine, pralidoxime, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029454\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029458\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11992 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-2.133.93.82-D9A3241E76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22355=[""].join("\n");
var outline_f21_53_22355=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4302652\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029451\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029450\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029454\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029455\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029457\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029453\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029458\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029459\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?43/24/44421?source=related_link\">",
"      Atropine and pralidoxime: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_53_22356="Nephrology pattern 11 answer";
var content_f21_53_22356=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F50449&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F50449&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nephrology pattern 11 answer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mixed cryoglobulinemia. Light micrograph in mixed cryoglobulinemia showing large cryoprecipitates occluding many of the capillary loops (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22356=[""].join("\n");
var outline_f21_53_22356=null;
var title_f21_53_22357="Microbiology and epidemiology of Q fever";
var content_f21_53_22357=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Microbiology and epidemiology of Q fever",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22357/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22357/contributors\">",
"     Didier Raoult, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22357/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22357/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22357/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22357/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/53/22357/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Q fever is a zoonotic infection caused by the pathogen Coxiella burnetii, which can cause acute or chronic disease with protean manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/1\">",
"     1",
"    </a>",
"    ]. The designation Q fever (from Query) was made in 1935 following an outbreak of febrile illness in an abattoir in Queensland, Australia.",
"   </p>",
"   <p>",
"    The microbiology and epidemiology of Q fever will be reviewed here. The clinical features and treatment of Q fever and Q fever endocarditis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12502?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Q fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15255?source=see_link\">",
"     \"Q fever endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. burnetii is a short, pleomorphic rod that is a strict intracellular bacterium. In mammals, the usual host cell of C. burnetii is the macrophage, which is unable to kill the bacterium. Coxiella burnetii lives and multiplies in a single, large, acidic vacuole, which results from the fusion of cell lysosomes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/2\">",
"     2",
"    </a>",
"    ]. While previously designated as a Rickettsia, C. burnetii has been re-classified as a Proteobacteria, which is closer to Legionella and Francisella [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    C. burnetii can be cultivated in embryonated eggs, laboratory animals, and in vitro cell culture systems [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Recently it was cultured in axenic medium in microaerophilic conditions at atmosphere [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/5\">",
"     5",
"    </a>",
"    ]. A sporulation-like process protects the organism from the external environment, where it can survive for long periods of time.",
"   </p>",
"   <p>",
"    An important characteristic of C. burnetii is its antigenic variation, called &ldquo;phase variation&rdquo;. When isolated from animals or humans, C. burnetii express phase I antigen and are highly infectious; a single bacterium is sufficient to infect a human. After subculturing C. burnetii in cells or embryonated eggs, modification of its lipopolysaccharide (LPS) capsule results in an antigenic shift to the phase II form, which is not infectious. This antigenic shift can be measured and forms the basis for differentiating acute from chronic Q fever [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1040523\">",
"    <span class=\"h2\">",
"     Geographic and temporal distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;The geographic distribution of Q fever is worldwide with a few exceptions, such as New Zealand. Large outbreaks have been reported in Switzerland, Great Britain, Germany, and in southern France [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/6\">",
"     6",
"    </a>",
"    ]. In North America, Nova Scotia has been the location of a significant number of cases. The largest outbreak ever described has occurred in the Netherlands in 2009, where it was previously unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/7\">",
"     7",
"    </a>",
"    ]. Cases of Q fever have also been reported in armed forces personnel returning from Iraq [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since the clinical presentation is nonspecific, recognition of cases depends upon astute clinicians and the availability of a reference laboratory [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, incidence figures for the disease vary widely. In southern France, the numbers of cases and outbreaks related to acute Q fever have steadily increased; in 2009, 4 percent of blood samples sent for serologic testing were reactive compared with 1 percent in 1989 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cases of acute Q fever in Europe occur more frequently in spring and early summer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Reservoirs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mammals, birds, and arthropods may be reservoirs for C. burnetii, but the main reservoir is ticks [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/1\">",
"     1",
"    </a>",
"    ]. The most commonly identified sources of human infection are farm animals, such as cattle, goats, and sheep. However, pets, including cats, rabbits, pigeons [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/12\">",
"     12",
"    </a>",
"    ], and dogs may serve as sources of urban outbreaks of human disease. Wild rats have been suspected as a reservoir for outbreaks in Great Britain.",
"   </p>",
"   <p>",
"    Infected mammals shed C. burnetii in their urine, feces, milk, and placenta. Q fever can cause abortions in sheep and goats and low birthweight in offspring of cattle. High concentrations of C. burnetii (up to 10(9) bacteria per gram of tissue) may occur in the placenta of infected animals [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Routes of transmission to humans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Humans are incidental hosts for infection with C. burnetii. Occupational exposure to C. burnetii among veterinarians may occur through inhalation of contaminated aerosols arising from the placenta or parturient fluids of infected livestock [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/1,11\">",
"     1,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    C. burnetii human infection has also resulted via the following routes: a) transplacental transmission to the fetus, b) intradermal inoculation and c) blood transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Consumption of raw milk is an additional cause of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/16\">",
"     16",
"    </a>",
"    ]. Aerosol transmission through a contaminated air conditioning system was implicated in a large outbreak among 322 students in an urban school in Israel [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22247?source=see_link\">",
"     \"Identifying and managing casualties of biological terrorism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Human to human transmission of infection is uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/14,18\">",
"     14,18",
"    </a>",
"    ], and nosocomial human to human transmission has not been described. Transmission of C. burnetii during intercourse was implicated in a single case report [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/19\">",
"     19",
"    </a>",
"    ]. The wife of a patient with occupationally-acquired Q fever developed the infection 15 days after sexual intercourse. She had no other known exposure to C. burnetii, and C. burnetii DNA was detected using polymerase chain reaction (PCR) in the husband's semen.",
"   </p>",
"   <p>",
"    Exposure to soil and standing water has also been postulated as possible reservoirs of C. burnetii infection:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A case-control study in French Guiana found that patients with Q fever were more likely to have engaged in activities near a forest compared with controls [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/20\">",
"       20",
"      </a>",
"      ]. Since no animal reservoirs of infection were found, and the spatial distribution of cases was wide, the presumed mechanism of transmission was through soil rather than a focal point with animal contamination.",
"     </li>",
"     <li>",
"      In one serologic study of 508 veterinarians, risk factors associated with C. burnetii seropositivity included interactions with cattle, swine, or wildlife and routine contact with pond water, a novel observation that requires further study [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Persons at risk for infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals at highest risk for acquisition of Q fever are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persons in contact with farm animals [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/22\">",
"       22",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Individuals living downwind from farms and contaminated manure, straw, or dust",
"     </li>",
"     <li>",
"      Laboratory personnel working with C. burnetii",
"     </li>",
"     <li>",
"      Abattoir workers",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Occupational exposure is the most common risk factor for acquisition. Antibodies to C. burnetii were found in 22 percent of 508 veterinarians in one seroepidemiologic survey [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/21\">",
"     21",
"    </a>",
"    ]. An unusual occupational exposure occurred in four employees of a cosmetics supply factory where ovine fetal products were used in the manufacturing of cosmetics [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Q fever can occur in any age group, but infection is most common between the ages of 30 and 70 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/11\">",
"     11",
"    </a>",
"    ]. Men are more frequently diagnosed with Q fever than women, although this may be related to the fact that women and children are more likely to have asymptomatic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. The clinical manifestations of Q fever may also vary according to the host. In a large retrospective review of 1383 cases occurring in France over a 14-year time period, hepatitis was more likely to occur in younger patients while pneumonia was more commonly seen in elderly patients and those who were HIV-infected [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/24\">",
"     24",
"    </a>",
"    ]. Endocarditis was the predominant manifestation among the patients with chronic Q fever, most of whom had preexisting valvular disease. Patients with chronic Q fever were usually older or immunocompromised compared with those with the acute form of the disease. A previous smaller study from France confirmed these findings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whether Q fever is more common in HIV-infected persons is unclear. In one retrospective study performed prior to the era of potent antiretroviral therapy, the incidence of Q fever was 13 times higher among HIV-infected patients compared with a blood donor group [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/27\">",
"     27",
"    </a>",
"    ]. In a 2008 survey of patients hospitalized with fever in Tanzania, 483 were tested for Q fever and 5 percent were diagnosed with acute infection; HIV serostatus was not associated Q fever, although approximately one-quarter of the inpatients were HIV-infected [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acquisition of Q fever infection during pregnancy increases the risk of obstetric complications, particularly if the woman is infected during early gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/29-32\">",
"     29-32",
"    </a>",
"    ]. Infected pregnant women may develop fever, spontaneous abortion, or premature labor [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/33\">",
"     33",
"    </a>",
"    ]. Intrauterine growth retardation, intrauterine death, and oligoamnios have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1040467\">",
"    <span class=\"h2\">",
"     Q fever as a reportable disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Q fever became a nationally reportable disease in the United States in 1999. C. burnetii is also a potential bioterrorism agent. Because of the increased surveillance for C. burnetii after the terrorist attacks of 2001, reported cases of Q fever have increased by 6.5-fold from 26 cases in 2001 to 169 cases in 2006 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22357/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22247?source=see_link&amp;anchor=H20472973#H20472973\">",
"     \"Identifying and managing casualties of biological terrorism\", section on 'Organisms of concern'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1040921\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Q fever is a zoonotic infection caused by the pathogen Coxiella burnetii that has both acute and chronic manifestations. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      C. burnetii is a short, pleomorphic rod that is an intracellular bacterium, recently cultured in axenic medium. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An important characteristic of C. burnetii is its antigenic variation, called phase variation. When isolated from animals or humans, C. burnetii express phase I antigen and are highly infectious. After laboratory cultivation, modification of the organism&rsquo;s capsule results in an antigenic shift to the phase II form, which is not infectious. This antigenic shift can be measured and is the basis on which acute and chronic Q fever are differentiated. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Q fever has a worldwide distribution. Mammals, birds, and arthropods may be reservoirs for C. burnetii, but the main reservoir is ticks. The most commonly identified sources of human infection are farm animals such as cattle, goats, and sheep. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Reservoirs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Human exposure to C. burnetii may occur as a result from inhalation of contaminated aerosols arising from the placenta or parturient fluids of infected livestock or from contaminated secretions and birth fluids on the surface of newborn animals. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Routes of transmission to humans'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Occupational exposure is the most common form of acquisition (eg, veterinarians). Other forms of transmission include transplacental, intradermal inoculation and blood transfusions. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Routes of transmission to humans'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Q fever became a nationally reportable disease in the United States in 1999. C. burnetii is also a potential bioterrorism agent. (See",
"      <a class=\"local\" href=\"#H1040467\">",
"       'Q fever as a reportable disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/1\">",
"      Raoult D, Marrie T. Q fever. Clin Infect Dis 1995; 20:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/2\">",
"      Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J Infect Dis 1992; 166:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/3\">",
"      Stein A, Saunders NA, Taylor AG, Raoult D. Phylogenic homogeneity of Coxiella burnetii strains as determinated by 16S ribosomal RNA sequencing. FEMS Microbiol Lett 1993; 113:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/4\">",
"      Raoult D. Q fever: still a query after all these years. J Med Microbiol 1996; 44:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/5\">",
"      Omsland A, Cockrell DC, Howe D, et al. Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc Natl Acad Sci U S A 2009; 106:4430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/6\">",
"      Hackert VH, van der Hoek W, Dukers-Muijrers N, et al. Q fever: single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region. Clin Infect Dis 2012; 55:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/7\">",
"      Cilla G, Montes M, Perez-Trallero E. Q fever in the Netherlands - what matters is seriousness of disease rather than quantity. Euro Surveill 2008; 13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/8\">",
"      Anderson AD, Smoak B, Shuping E, et al. Q fever and the US military. Emerg Infect Dis 2005; 11:1320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/9\">",
"      Leung-Shea C, Danaher PJ. Q fever in members of the United States armed forces returning from Iraq. Clin Infect Dis 2006; 43:e77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/10\">",
"      Frankel D, Richet H, Renvois&eacute; A, Raoult D. Q fever in France, 1985-2009. Emerg Infect Dis 2011; 17:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/11\">",
"      Tissot Dupont H, Raoult D, Brouqui P, et al. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med 1992; 93:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/12\">",
"      Stein A, Raoult D. Pigeon pneumonia in provence: a bird-borne Q fever outbreak. Clin Infect Dis 1999; 29:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/13\">",
"      Ben Amara A, Ghigo E, Le Priol Y, et al. Coxiella burnetii, the agent of Q fever, replicates within trophoblasts and induces a unique transcriptional response. PLoS One 2010; 5:e15315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/14\">",
"      Racult D, Stein A. Q fever during pregnancy--a risk for women, fetuses, and obstetricians. N Engl J Med 1994; 330:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/15\">",
"      Pantanowitz L, Telford SR, Cannon ME. Tick-borne diseases in transfusion medicine. Transfus Med 2002; 12:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/16\">",
"      Signs KA, Stobierski MG, Gandhi TN. Q fever cluster among raw milk drinkers in Michigan, 2011. Clin Infect Dis 2012; 55:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/17\">",
"      Amitai Z, Bromberg M, Bernstein M, et al. A large Q fever outbreak in an urban school in central Israel. Clin Infect Dis 2010; 50:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/18\">",
"      Osorio S, Sarri&aacute; C, Gonz&aacute;lez-Ruano P, et al. Nosocomial transmission of Q fever. J Hosp Infect 2003; 54:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/19\">",
"      Milazzo A, Hall R, Storm PA, et al. Sexually transmitted Q fever. Clin Infect Dis 2001; 33:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/20\">",
"      Gardon J, H&eacute;raud JM, Laventure S, et al. Suburban transmission of Q fever in French Guiana: evidence of a wild reservoir. J Infect Dis 2001; 184:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/21\">",
"      Whitney EA, Massung RF, Candee AJ, et al. Seroepidemiologic and occupational risk survey for Coxiella burnetii antibodies among US veterinarians. Clin Infect Dis 2009; 48:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/22\">",
"      Centers for Disease Control and Prevention (CDC). Notes from the field: Q fever outbreak associated with goat farms--Washington and Montana, 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/23\">",
"      Wade AJ, Cheng AC, Athan E, et al. Q fever outbreak at a cosmetics supply factory. Clin Infect Dis 2006; 42:e50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/24\">",
"      Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 2000; 79:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/25\">",
"      Raoult D, Marrie T, Mege J. Natural history and pathophysiology of Q fever. Lancet Infect Dis 2005; 5:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/26\">",
"      Brouqui P, Dupont HT, Drancourt M, et al. Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med 1993; 153:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/27\">",
"      Raoult D, Levy PY, Dupont HT, et al. Q fever and HIV infection. AIDS 1993; 7:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/28\">",
"      Prabhu M, Nicholson WL, Roche AJ, et al. Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania. Clin Infect Dis 2011; 53:e8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/29\">",
"      Breteler JK, Oudhoff JP, Munster JM, et al. Risks, trust and knowledge: determinants of pregnant women's decisions regarding participation in a future Q fever screening and treatment program during a large epidemic in The Netherlands. Prenat Diagn 2011; 31:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/30\">",
"      Munster JM, Leenders AC, van der Hoek W, et al. Cost-effectiveness of a screening strategy for Q fever among pregnant women in risk areas: a clustered randomized controlled trial. BMC Womens Health 2010; 10:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/31\">",
"      Denman J, Woods M. Acute Q fever in pregnancy: report and literature review. Intern Med J 2009; 39:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/32\">",
"      Carcopino X, Raoult D, Bretelle F, et al. Q Fever during pregnancy: a cause of poor fetal and maternal outcome. Ann N Y Acad Sci 2009; 1166:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/33\">",
"      Raoult D, Fenollar F, Stein A. Q fever during pregnancy: diagnosis, treatment, and follow-up. Arch Intern Med 2002; 162:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/34\">",
"      Centers for Disease Control and Prevention (CDC), Jajosky RA, Hall PA, et al. Summary of notifiable diseases--United States, 2004. MMWR Morb Mortal Wkly Rep 2006; 53:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/35\">",
"      Karakousis PC, Trucksis M, Dumler JS. Chronic Q fever in the United States. J Clin Microbiol 2006; 44:2283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22357/abstract/36\">",
"      Raoult D. Reemergence of Q fever after 11 September 2001. Clin Infect Dis 2009; 48:558.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5526 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-88.81.100.162-4217E6CC24-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22357=[""].join("\n");
var outline_f21_53_22357=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1040921\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1040523\">",
"      Geographic and temporal distribution",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Reservoirs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Routes of transmission to humans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Persons at risk for infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1040467\">",
"      Q fever as a reportable disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1040921\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/13/12502?source=related_link\">",
"      Clinical manifestations and diagnosis of Q fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22247?source=related_link\">",
"      Identifying and managing casualties of biological terrorism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/57/15255?source=related_link\">",
"      Q fever endocarditis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_53_22358="Musculoskeletal complications in diabetes mellitus";
var content_f21_53_22358=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Musculoskeletal complications in diabetes mellitus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22358/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22358/contributors\">",
"     Lesley D Hordon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22358/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22358/contributors\">",
"     Ira N Targoff, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22358/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22358/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22358/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/53/22358/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of musculoskeletal conditions have been associated with diabetes mellitus (",
"    <a class=\"graphic graphic_table graphicRef80533 \" href=\"UTD.htm?21/25/21915\">",
"     table 1",
"    </a>",
"    ). These problems are important to recognize because they often respond to treatment, preventing pain and disability and improving quality of life. Specific arthropathies of the hand and shoulder are discussed in this review. The relationship of diabetes with osteoarthritis is not so clear, and the data that bear on the association, or lack thereof, are also briefly mentioned.",
"   </p>",
"   <p>",
"    There are several other musculoskeletal complications of diabetes mellitus which are discussed separately. These include limited joint mobility, neuropathic arthropathy (eg, Charcot joint), bone disease, and diabetic muscle infarction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12534?source=see_link\">",
"     \"Limited joint mobility in diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39527?source=see_link\">",
"     \"Diabetic neuropathic arthropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/26/11687?source=see_link\">",
"     \"Bone disease in diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1526?source=see_link\">",
"     \"Diabetic muscle infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HAND ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hand abnormalities are common in diabetic patients, reflecting pathologic changes in the microvasculature, connective tissue, and peripheral nerves. One study, for example, evaluated 100 diabetic patients selected randomly in an outpatient clinic. Hand abnormalities were observed in 50 patients, and more than one abnormality was found in 26 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/1\">",
"     1",
"    </a>",
"    ]. Furthermore, 25 of the 50 patients with hand syndromes were disabled to such an extent that surgery was recommended. Carpal tunnel syndrome, Dupuytren's contracture, flexor tenosynovitis, and limited joint mobility were each present in approximately 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study of 200 patients with type 1 or type 2 diabetes and 100 controls, the prevalence of hand or shoulder disorders was higher in the diabetic patients than in controls and correlated with the duration, but not the type, of diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Carpal tunnel syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carpal tunnel syndrome (CTS) is a painful disorder caused by compression of the median nerve between the carpal ligament and other structures within the carpal tunnel. It has been reported in up to 20 percent of diabetic patients, but the incidence rises to 75 percent in those with limited joint mobility [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. Furthermore, diabetes has been reported in 6 to 17 percent of all cases of CTS [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/4,5\">",
"     4,5",
"    </a>",
"    ], and CTS may be more common in those with pre-diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=see_link\">",
"     \"Clinical manifestations and diagnosis of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Two studies comparing two groups of diabetic and nondiabetic patients undergoing carpal tunnel release showed clinical [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/7\">",
"     7",
"    </a>",
"    ] and neurophysiological [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/8\">",
"     8",
"    </a>",
"    ] outcomes to be similar in both groups, although the diabetic patients were more likely to report the persistence of cold intolerance.",
"   </p>",
"   <p>",
"    Median nerve entrapment in diabetes is presumably due to the connective tissue changes which also lead to limited joint mobility. Carpal tunnel syndrome is associated with the duration of diabetes but not with metabolic control, nephropathy, or retinopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12534?source=see_link\">",
"     \"Limited joint mobility in diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/62/44008?source=see_link\">",
"     \"Treatment of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Dupuytren's",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dupuytren's contracture is characterized by fibrosis in and around the palmar fascia, with nodule formation and contracture of the palmar fascia leading to flexion contractures of the digits. Many associations have been reported, including racial and genetic factors, chronic liver disease, and diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/9\">",
"     9",
"    </a>",
"    ]. Depending upon the criteria used for diagnosis, Dupuytren's contractures have been reported in 16 to 42 percent of diabetic outpatients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/1,10\">",
"     1,10",
"    </a>",
"    ]. The prevalence increases with age and the duration of diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/54/39783?source=see_link\">",
"     \"Dupuytren's contracture\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Flexor tenosynovitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tenosynovitis of the flexor tendon of the finger (trigger finger) in diabetes is characterized by palpable nodule formation and thickening localized to the flexor tendon or sheath and by locking phenomena. The ring finger, middle finger, and thumb are most often affected, and the condition is sometimes bilateral [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19141?source=see_link\">",
"     \"Trigger finger (stenosing flexor tenosynovitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Flexor tenosynovitis has been reported in 5 percent of a series of 250 patients with type 1 diabetes aged 3 to 38 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/11\">",
"     11",
"    </a>",
"    ] and in 20 percent of 100 patients with type 1 or type 2 diabetes aged 19 to 62 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/1\">",
"     1",
"    </a>",
"    ]. The prevalence of trigger finger is related to the duration of diabetes but not to metabolic control. Collagen abnormalities induced by diabetes mellitus are thought to be responsible. Diabetics are more likely than nondiabetics to have multiple digit involvement with stenosing flexor tenosynovitis (trigger finger), although it can also occur in nondiabetics; diabetic limited joint mobility has also been associated with multiple digit involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/12\">",
"     12",
"    </a>",
"    ]. Local glucocorticoid injection may be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/13\">",
"     13",
"    </a>",
"    ], but some patients require repeated surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diabetic sclerodactyly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sclerodactyly is characterized by thickening and waxiness of the skin most marked on the dorsa of the fingers. It is associated with limited joint mobility, although it can occur without joint involvement. The skin changes resemble those in scleroderma. However, the Raynaud phenomena, ulceration, calcinosis, and tapering are absent, and autoantibodies are negative (pseudoscleroderma) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The frequency of skin changes correlates with the duration of diabetes, although skin changes have been described in children with diabetes of recent onset [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/15\">",
"     15",
"    </a>",
"    ]. Other than improving glycemic control, which is of theoretical benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/13\">",
"     13",
"    </a>",
"    ], no treatment exists for this condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Reflex sympathetic dystrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reflex sympathetic dystrophy (also known as complex regional pain syndrome I) is characterized by severe pain or burning sensation, most commonly in the hand or foot, with associated swelling, trophic skin changes, and signs or symptoms of vasomotor instability. When the hand is affected, there may be associated pain or limitation of the ipsilateral shoulder (shoulder-hand syndrome).",
"   </p>",
"   <p>",
"    Reflex sympathetic dystrophy may be bilateral, and bone films characteristically show patchy osteoporosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/16\">",
"     16",
"    </a>",
"    ]. It is said to be more common in diabetes, but this association is not well-documented. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32344?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SHOULDER PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two main types of shoulder problems, adhesive capsulitis (frozen shoulder) and calcific periarthritis (calcific tendinitis), have been described in diabetic patients. The prevalence of adhesive capsulitis in patients with diabetes depends upon the criteria used for diagnosis and upon the population studied. It can vary substantially between studies, and many studies do not use radiographs to exclude osteoarthritis.",
"   </p>",
"   <p>",
"    Adhesive capsulitis has been reported in 19 to 29 percent of diabetics compared with approximately 5 percent of controls [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Increased age, longer duration of diabetes, the presence of limited joint mobility, and Dupuytren's contractures were also associated with an increased risk of painful capsulitis; retinopathy was also more frequent in those with capsulitis, while neuropathy and heavy proteinuria were not [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/18\">",
"     18",
"    </a>",
"    ]. A subsequent study of 865 diabetic patients found a prevalence of shoulder pain of 26 percent, compared with 5 percent of general medical patients, but only 4 percent of the diabetics fulfilled the strict criteria for adhesive capsulitis used, compared with 0.5 percent of medical patients. Only duration of diabetes was associated with adhesive capsulitis in this study [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/19\">",
"     19",
"    </a>",
"    ]. In contrast, shoulder capsulitis was found in 25 percent of a series of 96 diabetics and was associated with retinopathy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neuropathy. In this series, 75 percent of diabetics had locomotor problems, most often with the upper limb, and shoulder and hand problems showed a significant association with poorer glycemic control [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/7/33912?source=see_link\">",
"     \"Frozen shoulder (adhesive capsulitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Conversely, in a series of 60 patients with capsulitis, overt or latent diabetes was found in 17 (28 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/21\">",
"     21",
"    </a>",
"    ]. Soft tissue calcification with shoulder periarthritis also appears to occur three times more frequently in diabetics than in controls, although only one-third are symptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adhesive capsulitis is a common cause of shoulder pain in diabetics. One report, for example, evaluated 60 diabetic patients with shoulder pain; 58 percent had adhesive capsulitis, while 28 percent had tendinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A link between adhesive capsulitis and limited joint mobility has also been postulated, but the data are conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/17,24\">",
"     17,24",
"    </a>",
"    ]. An association has been suggested in one report of patients with relatively painless loss of movement. Limited joint mobility can affect the shoulder joint, and some of these subjects may not have had a true capsulitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     OSTEOARTHRITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity is a risk factor for both osteoarthritis of the knee [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/25\">",
"     25",
"    </a>",
"    ] and for type 2 diabetes. It is not clear if diabetes mellitus itself, independent of the mechanical and metabolic effects of obesity, is a risk factor for osteoarthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. There is increasing interest in the influence of the metabolic syndrome on the pathogenesis of osteoarthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22358/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     LIMITED JOINT MOBILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited joint mobility is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12534?source=see_link\">",
"     \"Limited joint mobility in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     NEUROPATHIC ARTHROPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuropathic arthropathy (eg, Charcot joint) is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39527?source=see_link\">",
"     \"Diabetic neuropathic arthropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     BONE DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of diabetes on bone are discussed in detail in another review. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/26/11687?source=see_link\">",
"     \"Bone disease in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIABETIC MUSCLE INFARCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous infarction of muscle is a rare condition which usually affects patients with longstanding and poorly controlled diabetes mellitus. Affected patients present with the acute onset of painful swelling of the thigh or, less commonly, the calf that then evolves over days or weeks. Diabetic muscle infarction is discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1526?source=see_link\">",
"     \"Diabetic muscle infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/41/31377?source=see_link\">",
"       \"Patient information: Dupuytren&rsquo;s contracture (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1757937\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A variety of musculoskeletal conditions have been associated with diabetes mellitus (",
"      <a class=\"graphic graphic_table graphicRef80533 \" href=\"UTD.htm?21/25/21915\">",
"       table 1",
"      </a>",
"      ). The prevalence of hand or shoulder disorders is higher in diabetic patients than in controls and correlates with the duration, but not the type, of diabetes. Hand abnormalities are common, reflecting pathologic changes in the microvasculature, connective tissue, and peripheral nerves. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Hand abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Carpal tunnel syndrome (CTS) has been reported in up to 20 percent of diabetic patients, but the incidence rises to 75 percent in those with limited joint mobility. Diabetes has been reported in 6 to 17 percent of all cases of CTS. CTS is associated with the duration of diabetes but not with metabolic control, nephropathy, or retinopathy, and it responds well to surgical treatment. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Carpal tunnel syndrome'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=see_link\">",
"       \"Clinical manifestations and diagnosis of carpal tunnel syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dupuytren's contractures have been reported in about 15 to 40 percent of diabetic outpatients. The prevalence increases with age and the duration of diabetes. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Dupuytren's'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Tenosynovitis of the flexor tendon of the finger (trigger finger) has been reported in about 5 to 20 percent of patients with diabetes and may involve multiple digits. The prevalence of trigger finger is related to the duration of diabetes but not to metabolic control. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Flexor tenosynovitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diabetic sclerodactyly is characterized by thickening and waxiness of the skin most marked on the dorsa of the fingers and is often associated with limited joint mobility. The skin changes resemble those in scleroderma, but other features, such as Raynaud phenomena, ulceration, calcinosis, and tapering, are absent, as are autoantibodies. The frequency of skin changes correlates with the duration of diabetes. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diabetic sclerodactyly'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adhesive capsulitis (frozen shoulder) and calcific periarthritis (calcific tendinitis) are each three to four times more common in diabetic patients than in controls. Increased age, longer duration of diabetes, the presence of limited joint mobility, Dupuytren's contractures, and retinopathy were associated with an increased risk of painful capsulitis in some studies. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Shoulder pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other musculoskeletal problems in diabetes may include limited joint mobility, neuropathic arthropathy, bone disease, and diabetic muscle infarction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12534?source=see_link\">",
"       \"Limited joint mobility in diabetes mellitus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39527?source=see_link\">",
"       \"Diabetic neuropathic arthropathy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/26/11687?source=see_link\">",
"       \"Bone disease in diabetes mellitus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1526?source=see_link\">",
"       \"Diabetic muscle infarction\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/1\">",
"      Gamstedt A, Holm-Glad J, Ohlson CG, Sundstr&ouml;m M. Hand abnormalities are strongly associated with the duration of diabetes mellitus. J Intern Med 1993; 234:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/2\">",
"      Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med 2002; 112:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/3\">",
"      Chaudhuri KR, Davidson AR, Morris IM. Limited joint mobility and carpal tunnel syndrome in insulin-dependent diabetes. Br J Rheumatol 1989; 28:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/4\">",
"      Phalen GS. Reflections on 21 years' experience with the carpal-tunnel syndrome. JAMA 1970; 212:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/5\">",
"      BLODGETT RC Jr, LIPSCOMB PR, HILL RW. Incidence of hematologic disease in patients with carpal tunnel syndrome. JAMA 1962; 182:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/6\">",
"      Gulliford MC, Latinovic R, Charlton J, Hughes RA. Increased incidence of carpal tunnel syndrome up to 10 years before diagnosis of diabetes. Diabetes Care 2006; 29:1929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/7\">",
"      Thomsen NO, Cederlund R, Ros&eacute;n I, et al. Clinical outcomes of surgical release among diabetic patients with carpal tunnel syndrome: prospective follow-up with matched controls. J Hand Surg Am 2009; 34:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/8\">",
"      Thomsen NO, Ros&eacute;n I, Dahlin LB. Neurophysiologic recovery after carpal tunnel release in diabetic patients. Clin Neurophysiol 2010; 121:1569.",
"     </a>",
"    </li>",
"    <li>",
"     Sibbitt WL. Fibrosing syndromes: diabetic stiff hand syndrome, Dupuytren's contracture and plantar fasciitis. In: Arthritis and Allied Conditions, 11th Edition, McCarty DJ (Ed), Lea &amp; Febiger, Philadelphia 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/10\">",
"      Noble J, Heathcote JG, Cohen H. Diabetes mellitus in the aetiology of Dupuytren's disease. J Bone Joint Surg Br 1984; 66:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/11\">",
"      Yosipovitch G, Yosipovitch Z, Karp M, Mukamel M. Trigger finger in young patients with insulin dependent diabetes. J Rheumatol 1990; 17:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/12\">",
"      Kameyama M, Meguro S, Funae O, et al. The presence of limited joint mobility is significantly associated with multiple digit involvement by stenosing flexor tenosynovitis in diabetics. J Rheumatol 2009; 36:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/13\">",
"      Kapoor A, Sibbitt WL Jr. Contractures in diabetes mellitus: the syndrome of limited joint mobility. Semin Arthritis Rheum 1989; 18:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/14\">",
"      Jelinek JE. The skin in diabetes. Diabet Med 1993; 10:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/15\">",
"      Seibold JR. Digital sclerosis in children with insulin-dependent diabetes mellitus. Arthritis Rheum 1982; 25:1357.",
"     </a>",
"    </li>",
"    <li>",
"     Kozin F. Painful shoulder and the reflex sympathetic dystrophy syndrome. In: Arthritis and Allied Conditions, 11th, McCarty DJ (Ed), Lea and Febiger, Philadelphia 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/17\">",
"      Pal B, Anderson J, Dick WC, Griffiths ID. Limitation of joint mobility and shoulder capsulitis in insulin- and non-insulin-dependent diabetes mellitus. Br J Rheumatol 1986; 25:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/18\">",
"      Balci N, Balci MK, T&uuml;z&uuml;ner S. Shoulder adhesive capsulitis and shoulder range of motion in type II diabetes mellitus: association with diabetic complications. J Diabetes Complications 1999; 13:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/19\">",
"      Thomas SJ, McDougall C, Brown ID, et al. Prevalence of symptoms and signs of shoulder problems in people with diabetes mellitus. J Shoulder Elbow Surg 2007; 16:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/20\">",
"      Ramchurn N, Mashamba C, Leitch E, et al. Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes. Eur J Intern Med 2009; 20:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/21\">",
"      Lequesne M, Dang N, Bensasson M, Mery C. Increased association of diabetes mellitus with capsulitis of the shoulder and shoulder-hand syndrome. Scand J Rheumatol 1977; 6:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/22\">",
"      Mavrikakis ME, Sfikakis PP, Kontoyannis SA, et al. Clinical and laboratory parameters in adult diabetics with and without calcific shoulder periarthritis. Calcif Tissue Int 1991; 49:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/23\">",
"      Mor&eacute;n-Hybbinette I, Moritz U, Scherst&eacute;n B. The clinical picture of the painful diabetic shoulder--natural history, social consequences and analysis of concomitant hand syndrome. Acta Med Scand 1987; 221:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/24\">",
"      Fisher L, Kurtz A, Shipley M. Association between cheiroarthropathy and frozen shoulder in patients with insulin-dependent diabetes mellitus. Br J Rheumatol 1986; 25:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/25\">",
"      Hochberg MC. Epidemiology of osteoarthritis: current concepts and new insights. J Rheumatol Suppl 1991; 27:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/26\">",
"      Forg&aacute;cs SS. Diabetes mellitus and rheumatic disease. Clin Rheum Dis 1986; 12:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/27\">",
"      Horn CA, Bradley JD, Brandt KD, et al. Impairment of osteophyte formation in hyperglycemic patients with type II diabetes mellitus and knee osteoarthritis. Arthritis Rheum 1992; 35:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22358/abstract/28\">",
"      Velasquez MT, Katz JD. Osteoarthritis: another component of metabolic syndrome? Metab Syndr Relat Disord 2010; 8:295.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5126 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-190.92.87.103-3E383B0E56-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22358=[""].join("\n");
var outline_f21_53_22358=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1757937\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HAND ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Dupuytren's",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Flexor tenosynovitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diabetic sclerodactyly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Reflex sympathetic dystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SHOULDER PAIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      OSTEOARTHRITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      LIMITED JOINT MOBILITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      NEUROPATHIC ARTHROPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      BONE DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIABETIC MUSCLE INFARCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1757937\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/5126\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5126|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/25/21915\" title=\"table 1\">",
"      Musculoskeletal disease in DM",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/26/11687?source=related_link\">",
"      Bone disease in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=related_link\">",
"      Clinical manifestations and diagnosis of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/31/1526?source=related_link\">",
"      Diabetic muscle infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39527?source=related_link\">",
"      Diabetic neuropathic arthropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/54/39783?source=related_link\">",
"      Dupuytren's contracture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32344?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/7/33912?source=related_link\">",
"      Frozen shoulder (adhesive capsulitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/15/12534?source=related_link\">",
"      Limited joint mobility in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/41/31377?source=related_link\">",
"      Patient information: Dupuytren&rsquo;s contracture (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/62/44008?source=related_link\">",
"      Treatment of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19141?source=related_link\">",
"      Trigger finger (stenosing flexor tenosynovitis)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_53_22359="Contact dermatitis berloque 1";
var content_f21_53_22359=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81457%7EDERM%2F68245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81457%7EDERM%2F68245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Berloque dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 346px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This adolescent developed hyperpigmented streaks from a photosensitizer in his sunscreen. After several days of erythema, the red patches became dark brown.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Kosman Sadek Zikry, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Berloque dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperpigmention stage of berloque dermatitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The Dermatology Online Atlas,",
"     <a href=\"file://www.dermis.net\" target=\"_blank\">",
"      www.dermis.net",
"     </a>",
"     . Copyright &copy; 2011. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22359=[""].join("\n");
var outline_f21_53_22359=null;
var title_f21_53_22360="Principles of laser and intense pulsed light for cutaneous lesions";
var content_f21_53_22360=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Principles of laser and intense pulsed light for cutaneous lesions",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22360/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22360/contributors\">",
"     George J Hruza, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22360/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22360/contributors\">",
"     Jeffrey S Dover, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22360/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22360/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/53/22360/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H31999019\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;When absorbed in sufficient amounts, light energy can induce changes in the skin. Lasers and intense pulsed light (IPL) devices allow for the delivery of light to the skin in a controlled manner. These devices are useful for achieving desired clinical effects in a variety of dermatologic conditions.",
"   </p>",
"   <p>",
"    The term laser is an acronym for light amplification by stimulated emission of radiation. Lasers deliver monochromatic, coherent, collimated, high intensity beams of light. In contrast, IPL devices are filtered flashlamps that emit polychromatic, noncoherent light in a broad range of wavelengths. Thus, IPL devices are dimmer and less powerful than lasers.",
"   </p>",
"   <p>",
"    For many years following the initial studies of the effects of lasers on the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/1-4\">",
"     1-4",
"    </a>",
"    ], the use of lasers was limited to nonselective coagulation and vaporization of tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/5\">",
"     5",
"    </a>",
"    ]. A revolution in the clinical utility of lasers occurred in the early 1980s with the development of the theory of selective photothermolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/6\">",
"     6",
"    </a>",
"    ]. This theory describes the parameters by which light can be used to selectively destroy targets in the skin through the selective absorption of light and spatial confinement of the effect. The majority of subsequent developments in laser technology for cutaneous disorders have been based upon this theory.",
"   </p>",
"   <p>",
"    Progress in laser and IPL technology has also involved the development of safer and more efficient methods of achieving the desired effects on skin. Cooling technology limits inadvertent damage to tissues adjacent to targeted sites, allowing higher levels of light energy to be directed towards the target. In addition, the implementation of fractionated laser technology for cutaneous resurfacing has allowed for the achievement of the desired cosmetic outcome with reduced healing time.",
"   </p>",
"   <p>",
"    The principles that govern the interactions between skin and laser light or IPL, and the types of these devices used in the treatment of skin will be discussed here. Background information on the production and basic characteristics of laser light, the treatment of cutaneous vascular and hyperpigmented lesions with laser light, and ablative laser resurfacing for skin rejuvenation are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/25/32151?source=see_link\">",
"     \"Basic principles of medical lasers\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17146?source=see_link\">",
"     \"Laser and light therapy for cutaneous vascular lesions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/9/9370?source=see_link\">",
"     \"Laser and light therapy for cutaneous hyperpigmentation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/36/1610?source=see_link\">",
"     \"Ablative laser resurfacing for skin rejuvenation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999027\">",
"    <span class=\"h1\">",
"     SKIN OPTICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough understanding of interactions between light and biologic tissue is critical for the selection of a laser or IPL device as well as the effective and safe use of the equipment. Light interacts with tissue in four major ways (",
"    <a class=\"graphic graphic_figure graphicRef69573 \" href=\"UTD.htm?33/32/34308\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Absorption &ndash;",
"      </strong>",
"      According to the Grothus-Draper law, absorption of light is required for light to exert effects (both beneficial and adverse) on tissue. Molecules that absorb light are called chromophores. Melanin, oxyhemoglobin, and water are examples of biologic chromophores that are frequently targeted with laser and IPL devices. Tattoo ink also functions as a chromophore, and is another common target in laser therapy. In most clinical settings, light absorbed into a target chromophore in the skin is converted to thermal energy, leading to heating and destruction of the chromophore.",
"     </li>",
"     <li>",
"      <strong>",
"       Scattering &ndash;",
"      </strong>",
"      Scattering of light describes the redirection of photons away from the primary direction of light travel. Dermal collagen is responsible for most light scattering in skin. When emitted light is scattered in the same direction as the primary beam or sideways, the power density of the beam attenuates with increasing depth. In contrast, light that is reflected back towards the source can increase the power density of the beam within the tissue. Scattering decreases with the use of long wavelengths of light and the delivery of light through large spot sizes. (See",
"      <a class=\"local\" href=\"#H31999082\">",
"       'Wavelength'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H31999113\">",
"       'Spot size'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Reflection &ndash;",
"      </strong>",
"      A portion of light directed towards the skin does not penetrate the skin; light can be reflected away from the surface of the skin without exerting a clinical effect. The stratum corneum is responsible for most reflection from the skin.",
"     </li>",
"     <li>",
"      <strong>",
"       Transmission",
"      </strong>",
"      &ndash; Light can pass through tissue without being absorbed, scattered, or reflected. No clinical effect occurs from light that simply passes through tissue.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The amount of light that penetrates deeply into the skin is dependent upon absorption by chromophores and light scattering. Due to reduced scattering and the relative paucity of superficial chromophores that absorb long wavelengths of light, long wavelengths penetrate more deeply into the skin and can be used to target structures in the mid or deep dermis. As an example, light in the near infrared (800 to 1200 nm) range is weakly absorbed by the biologic chromophores in skin and is minimally scattered due to the relatively long wavelength. Thus, a laser that emits light with a wavelength near 1100 nm will penetrate more than 2 mm into the skin, and can be used for targeting tattoo pigment in the deep dermis. [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999074\">",
"    <span class=\"h1\">",
"     SELECTIVE PHOTOTHERMOLYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical effect of a laser or IPL device is dependent upon both the properties of the light that irradiates the skin and the interaction of the light with chromophores, concepts that are well-explained by the theory of selective photothermolysis. This theory describes the methods by which light can be manipulated to induce the desired clinical effect. The following principles compose the theory of selective photothermolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The wavelength of light utilized should be absorbed preferentially by the target chromophore and must penetrate the skin sufficiently to reach its depth",
"     </li>",
"     <li>",
"      The light must be delivered in a period of time that is short enough to prevent the transfer of excessive heat to adjacent structures",
"     </li>",
"     <li>",
"      The energy delivered per unit area (fluence) must be sufficient to exert the desired therapeutic effect, but should also be at a level that minimizes collateral tissue damage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Application of the theory of selective photothermolysis led to the identification of laser parameters that are most effective for specific clinical indications. As an example, knowledge of the light parameters that effectively target hemoglobin led to the development of the 585 nm pulsed dye laser, which has been used for the management of port wine stains [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17146?source=see_link&amp;anchor=H10061356#H10061356\">",
"     \"Laser and light therapy for cutaneous vascular lesions\", section on 'Port wine stains'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1638142\">",
"    <span class=\"h1\">",
"     THERAPEUTIC PARAMETERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wavelength and pulse duration are the most important laser parameters that govern the effects of laser light on skin. Fluence, irradiance, and spot size are additional laser settings that influence clinical outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999082\">",
"    <span class=\"h2\">",
"     Wavelength",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chromophores absorb light most effectively at different wavelengths (",
"    <a class=\"graphic graphic_figure graphicRef74419 \" href=\"UTD.htm?21/34/22048\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef58203 \" href=\"UTD.htm?28/33/29211\">",
"     table 1",
"    </a>",
"    ). To exert the greatest effect, the laser wavelength should be near the maximum absorption of the target chromophore and should be of sufficient length to penetrate to the depth of the target.",
"    <strong>",
"    </strong>",
"   </p>",
"   <p>",
"    Because light scattering decreases with increasing wavelength, greater light penetration generally is achieved with longer wavelengths of light. The depth of penetration of ultraviolet, visible, and near infrared light into the skin follows the electromagnetic spectrum (near infrared&gt;red&gt;yellow&gt;green&gt;blue&gt;ultraviolet) (",
"    <a class=\"graphic graphic_figure graphicRef70045 \" href=\"UTD.htm?15/8/15502\">",
"     figure 3",
"    </a>",
"    ).",
"    <strong>",
"    </strong>",
"    In contrast to this pattern, high absorption of light by water molecules in the epidermis markedly limits the depth of penetration of light emitted from mid-infrared (2940 nm erbium:yttrium aluminum garnet) and far infrared (10,600 nm carbon dioxide) lasers (",
"    <a class=\"graphic graphic_figure graphicRef60561 \" href=\"UTD.htm?43/30/44516\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The selected wavelength should also be a wavelength for which minimum competition from other chromophores is present. If more than one chromophore is present in the target tissue, the absorption of light will be divided in relation to their relative absorption coefficients (measurements of the probability of light absorption by chromophores). In addition, a superficial chromophore can shield a deeper chromophore from irradiation. As an example, absorption of light by melanin in the epidermis can reduce the amount of light that reaches melanin in hair follicles, hemoglobin in dermal blood vessels, or tattoo pigment in the dermis.",
"    <strong>",
"    </strong>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999090\">",
"    <span class=\"h2\">",
"     Pulse duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pulse duration of the laser beam heavily affects the likelihood of achieving the desired clinical effect. The most appropriate pulse duration setting is determined by the thermal relaxation time of the target chromophore.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2286663\">",
"    <span class=\"h3\">",
"     Thermal relaxation time",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thermal relaxation time is defined as the amount of time it takes the temperature of a target to return to the ambient temperature following heating (",
"    <a class=\"graphic graphic_figure graphicRef78746 \" href=\"UTD.htm?23/29/24017\">",
"     figure 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Large objects lose heat much more slowly than small structures. Thus, the thermal relaxation time is heavily influenced by the size of the target (",
"    <a class=\"graphic graphic_table graphicRef66913 \" href=\"UTD.htm?10/25/10651\">",
"     table 2",
"    </a>",
"    ). As an example, the thermal relaxation time of a 50 to 100 &micro;M blood vessel in a port wine stain is on the order of a few milliseconds [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/8\">",
"     8",
"    </a>",
"    ]. In contrast, the thermal relaxation time of a melanosome measuring approximately 1 &micro;m is approximately 1 microsecond [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If an object is heated for a period equal to or shorter than its thermal relaxation time, the accumulated heat and resultant damage is confined to the target object alone. When a 50 &micro;M blood vessel in a port wine stain is irradiated with light from a pulsed dye laser with a pulse duration of approximately 1.5 milliseconds, the light is absorbed by oxyhemoglobin and the destruction is confined to the target vessel [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/10\">",
"     10",
"    </a>",
"    ]. This selective photothermolysis dramatically reduces the risk of scarring.",
"   </p>",
"   <p>",
"    In contrast, if an object is heated for longer than its thermal relaxation time, thermal diffusion leads to heating of surrounding structures. Prior to the advent of pulsed dye lasers, nonpulsed (continuous wave) argon lasers were used for the treatment of vascular lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Although light from argon lasers is well-absorbed by oxyhemoglobin, the long duration with which the light was administered led to excessive heating of surrounding structures and a relatively high risk of scarring. (See",
"    <a class=\"local\" href=\"#H31999177\">",
"     'Continuous and quasi-continuous wave lasers'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Similarly, the importance of pulse duration in successful selective photothermolysis is evident in traditional (nonfractionated) laser skin resurfacing with carbon dioxide (CO2) or erbium:yttrium aluminum garnet (Er:YAG) lasers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. The CO2 laser penetrates the skin to a depth of approximately 0.05 mm, and the thermal relaxation time of this thickness of tissue is approximately 1 millisecond. The delivery of light with pulse durations of less than 1 millisecond greatly minimizes collateral thermal damage during CO2 laser resurfacing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2286670\">",
"    <span class=\"h3\">",
"     Large versus small structures",
"    </span>",
"    &nbsp;&mdash;&nbsp;When heat is delivered slowly, small structures sometimes can be heated for longer durations than their thermal relaxation times without sustaining damage. This phenomenon allows for the selective destruction of large structures while smaller structures that contain the same chromophore or other chromophores with similar absorptive spectra are spared.",
"   </p>",
"   <p>",
"    For example, if small targets containing melanin, such as melanosomes in the epidermis, are heated slowly over 10 to 20 milliseconds (longer than their thermal relaxation time of 1 microsecond), accumulated heat will be released to the surrounding tissue without heating the melanosome or the surrounding structures sufficiently to cause tissue coagulation. In contrast, a hair follicle from a patient with dark-colored hair is a relatively large structure that contains a significant amount of melanin. The size of the follicle causes the structure to lose heat much more slowly than the melanosome; the thermal relaxation time of a hair follicle is approximately 20 milliseconds. When light is delivered with a pulse duration of 10 to 20 milliseconds, there is not sufficient time for the heat to dissipate to tissue surrounding the hair follicle, and the follicle is destroyed while the adjacent tissues and epidermal melanosomes remain intact. This property is used effectively for laser hair removal, and is of particular importance in laser hair removal in individuals with dark skin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999097\">",
"    <span class=\"h2\">",
"     Fluence",
"    </span>",
"    &nbsp;&mdash;&nbsp;As stated in the Grothus-Draper law, a sufficient amount of light energy has to be absorbed by a structure in order to produce a detectable effect [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/16\">",
"     16",
"    </a>",
"    ] (see",
"    <a class=\"local\" href=\"#H31999027\">",
"     'Skin optics'",
"    </a>",
"    above). Fluence is a measurement of the amount of energy delivered per unit area (",
"    <a class=\"graphic graphic_figure graphicRef78764 \" href=\"UTD.htm?6/21/6493\">",
"     figure 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For most pulsed lasers used for selective photothermolysis of vascular lesions, the fluences used during treatment range from 3 to 15",
"    <span class=\"nowrap\">",
"     J/cm",
"     <sup>",
"      2",
"     </sup>",
"     .",
"    </span>",
"    For IPL treatment of vascular lesions, higher fluences are often required, ranging from 15 to 30",
"    <span class=\"nowrap\">",
"     J/cm",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    or more. The higher level of energy necessary to achieve the desired clinical effect is attributed to the less selective targeting of chromophores by IPL devices. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17146?source=see_link\">",
"     \"Laser and light therapy for cutaneous vascular lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The destruction of very large structures, such as hair follicles, with laser or IPL usually requires high fluences (20 to 50",
"    <span class=\"nowrap\">",
"     J/cm",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    due to the amount of tissue that has to be heated to achieve thermal coagulation of these structures.",
"   </p>",
"   <p>",
"    Another indication for the use of high fluences (sometimes in excess of 100",
"    <span class=\"nowrap\">",
"     J/cm",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    is the use of long wavelength lasers such as the 1064 neodymium:yttrium aluminum garnet (Nd:YAG) laser to treat structures such as telangiectasias. The target chromophore in telangiectasias (oxyhemoglobin) has low affinity for this wavelength of light, and the delivery of high amounts of energy is necessary to heat the target structure to a level sufficient for coagulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999105\">",
"    <span class=\"h2\">",
"     Irradiance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Power describes the rate of energy delivery and is measured in Joules per second (watts). The irradiance relates this measurement to the size of the treated area, and describes the rate of energy delivery per unit area to an object",
"    <span class=\"nowrap\">",
"     (watts/cm",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/16\">",
"     16",
"    </a>",
"    ]. Irradiance is easily calculated from the laser power output and spot size (",
"    <a class=\"graphic graphic_figure graphicRef59820 \" href=\"UTD.htm?35/28/36300\">",
"     figure 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Irradiance essentially is a measurement of the intensity of energy delivery. Very high irradiance will achieve much faster heating of an object than low irradiance. Decreasing the pulse duration of a laser or IPL device without changing the energy setting will result in a higher level of irradiance.",
"   </p>",
"   <p>",
"    The relevance of irradiance in the clinical setting is supported by the observation that slow heating (low irradiance) coagulates tissue while fast heating (high irradiance) can vaporize tissue. At extremely high levels of irradiance (eg, megawatt or gigawatt per cm",
"    <sup>",
"     2",
"    </sup>",
"    ), such as is achieved with nanosecond pulse duration Q-switched lasers, heating is so rapid that targets shatter from photomechanical forces rather than vaporization. (See",
"    <a class=\"local\" href=\"#H31999185\">",
"     'Pulsed lasers'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Although fluence is commonly used when discussing settings of pulsed lasers and IPL devices, the lack of a fixed pulsed duration with continuous wave lasers makes irradiance the preferred unit of measurement when referring to the continuous wave devices. (See",
"    <a class=\"local\" href=\"#H31999177\">",
"     'Continuous and quasi-continuous wave lasers'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999113\">",
"    <span class=\"h2\">",
"     Spot size",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spot size is the diameter of the beam of light emitted from the laser or IPL device that hits the skin surface. Because fluence is a measurement of Joules delivered per square centimeter",
"    <span class=\"nowrap\">",
"     (J/cm",
"     <sup>",
"      2",
"     </sup>",
"     ),",
"    </span>",
"    one might assume that increasing the energy output of a laser in proportion to an increase in spot size would result in a similar effect on a larger area of tissue. However, scattering of light occurs to a greater degree with small spot sizes. Thus, the light energy that enters the target tissue is attenuated far more rapidly with the use of small spot sizes than with the use of large spot sizes.",
"   </p>",
"   <p>",
"    Spot size is most important when targeting structures in the mid to deep dermis with long pulsed lasers, such as the ruby, alexandrite, diode, and Nd:YAG lasers. A spot size of at least 7 to 10 mm is essential in this setting. The benefit of increasing spot size is minimal or nonexistent with spot sizes of 10 mm or greater. For targets in the epidermis or upper dermis, spot size is less important.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999121\">",
"    <span class=\"h1\">",
"     FRACTIONAL PHOTOTHERMOLYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractional photothermolysis is another method of maintaining tight control over the extent of laser light injury. The technique involves the use of infrared light, which is well-absorbed by water, to coagulate or ablate narrow columns of tissue called microthermal zones (MTZs) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/17\">",
"     17",
"    </a>",
"    ]. A pattern of thousands of MTZs (approximately 0.1 mm in diameter) is laid down during treatment. In general, the proportion of injured tissue represents 10 to 50 percent of the skin surface (",
"    <a class=\"graphic graphic_figure graphicRef53757 \" href=\"UTD.htm?38/15/39153\">",
"     figure 8",
"    </a>",
"    ). Skin between the columns is spared from injury. (See",
"    <a class=\"local\" href=\"#H31999193\">",
"     'Fractionated lasers'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999161\">",
"    <span class=\"h1\">",
"     SKIN COOLING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although laser or IPL treatments are often used to target structures in the dermis such as hair follicles, telangiectasias, or tattoos, the epidermis, which contains melanin, can absorb a significant amount of a visible laser light (",
"    <a class=\"graphic graphic_table graphicRef58203 \" href=\"UTD.htm?28/33/29211\">",
"     table 1",
"    </a>",
"    ). Excessive heating of the epidermis secondary to the absorption of light can lead to epidermal cell injury and death, resulting in hypopigmentation or hyperpigmentation.",
"   </p>",
"   <p>",
"    Almost all pulsed laser and IPL systems use some form of cooling. Cooling agents may be cold gases, liquids, or solids that are applied to the skin surface preceding, during, or after treatment.",
"   </p>",
"   <p>",
"    Cooling of the epidermis protects it from damage, thereby allowing for the delivery of higher amounts of light energy to the dermis. Cooling of the dermis has a similar effect, as it reduces the transfer of heat to adjacent, nontarget tissues. Pain reduction is another potential benefit of cooling [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The simplest method of cooling the skin involves the application of an ice cube or an ice-cold roller to the skin surface before treatment. However, most laser and IPL devices now use integrated cooling systems, which are easier to use and provide more reliable and consistent methods of cooling. For example, the epidermis and upper dermis may be cooled by the application of a metal plate or a chilled transparent window that is attached to the laser handpiece, or through a mechanism that blows cold air onto the treated site. A cryogen liquid spray also has been used to rapidly cool the epidermis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999169\">",
"    <span class=\"h1\">",
"     CLASSIFICATION OF DEVICES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The three major categories of lasers used in the treatment of skin include continuous wave lasers, pulsed lasers, and fractionated lasers (",
"    <a class=\"graphic graphic_table graphicRef72989 \" href=\"UTD.htm?31/7/31869\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999177\">",
"    <span class=\"h2\">",
"     Continuous and quasi-continuous wave lasers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuous wave lasers emit a continuous laser beam as long as the foot pedal or finger switch is depressed. Examples of continuous wave lasers include the argon, argon pumped tunable dye, krypton, and some CO2 lasers.",
"   </p>",
"   <p>",
"    Quasi-continuous wave lasers are very rapidly pulsing lasers, and include copper vapor, copper bromide, and potassium titanyl phosphate (KTP) lasers. Intervals between pulses are extremely short, and emitted light functions similarly to a continuous beam.",
"   </p>",
"   <p>",
"    With these lasers, long periods of continuous exposure to the laser beam or insufficient cooling time between pulses can lead to excessive heating of nontarget structures in the skin. In an attempt to reduce collateral damage with continuous wave lasers, automated scanning devices were designed to move the laser beams across the skin in predetermined patterns so that any individual point of skin would receive the laser beam for only a specific duration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/20\">",
"     20",
"    </a>",
"    ]. However, scanning devices were not always effective in preventing cutaneous damage. As a result, continuous wave lasers have been mostly supplanted by pulsed lasers due to the much better selectivity of the latter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999185\">",
"    <span class=\"h2\">",
"     Pulsed lasers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulsed lasers produce a laser beam that is emitted in short pulses with a long period (0.1 to 1 second) between pulses.",
"   </p>",
"   <p>",
"    Relatively long-pulsed lasers such as the 595 nm pulsed dye laser or the alexandrite 755 nm laser have pulses in the 1 to 50 millisecond range and peak powers in the kilowatt range. They are designed to selectively coagulate relatively large structures such as telangiectasias and hair follicles [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/21\">",
"     21",
"    </a>",
"    ]. The long pulse duration of these lasers minimizes collateral tissue damage during the delivery of the high amounts of energy required for the coagulation of these structures. (See",
"    <a class=\"local\" href=\"#H2286670\">",
"     'Large versus small structures'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Short-pulse lasers have pulse durations in the 5 to 100 nanosecond range, and include Q-switched ruby, Q-switched alexandrite, and Q-switched Nd:YAG lasers. These devices are used to target small structures such as melanosomes and tattoo ink particles [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/22\">",
"     22",
"    </a>",
"    ]. Q-switching refers to an electro-optical switch within the laser cavity that allows the release of all of the laser energy stored in the laser cavity in one brief powerful pulse. Power outputs in the megawatt to gigawatt range are common. The target is heated at such a rapid rate that it shatters and supersonic shockwaves are created in the tissue.",
"   </p>",
"   <p>",
"    Pulsed ablative CO2 and Er:YAG lasers have been used for laser skin resurfacing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/13\">",
"     13",
"    </a>",
"    ]. With the advent of fractionated laser systems for resurfacing, CO2 and Er:YAG lasers have fallen out of favor with most laser surgeons. They are still useful for precisely ablating superficial skin lesions while leaving behind a very narrow zone of thermal damage. Examples of indications for these lasers include rhinophyma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/23\">",
"     23",
"    </a>",
"    ], actinic cheilitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/24\">",
"     24",
"    </a>",
"    ], adenoma sebaceum, epidermal nevi, and deep rhytides.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999193\">",
"    <span class=\"h2\">",
"     Fractionated lasers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractional photothermolysis involves the use of light energy to create numerous narrow columns of coagulated or ablated skin (microthermal zones, MTZs) (",
"    <a class=\"graphic graphic_figure graphicRef53757 \" href=\"UTD.htm?38/15/39153\">",
"     figure 8",
"    </a>",
"    ). As healing occurs, remodeling of the affected epidermis and dermis contributes to changes in the appearance or texture of the skin. Fractionated lasers most commonly are used for skin resurfacing and the treatment of scars [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. They are divided into nonablative and ablative devices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5099189\">",
"    <span class=\"h3\">",
"     Nonablative",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonablative fractionated lasers thermally coagulate narrow vertical columns of epidermis and variable portions of the dermis. This is achieved with the use of near infrared lasers (1320, 1440, 1540, and 1550 nm). Near infrared lasers emit light that is absorbed by water in the skin to a lesser extent than light from mid and far infrared lasers, which are used for fractional ablation.",
"   </p>",
"   <p>",
"    Following treatment, the thermally coagulated epidermis is rapidly sloughed off and reepithelialization is completed within two to three days. The thermally coagulated dermis is gradually replaced with new collagen deposition and collagen remodeling. A series of treatments usually is necessary to gradually remodel the entire skin surface.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5099204\">",
"    <span class=\"h3\">",
"     Ablative",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ablative fractionated laser delivery creates ablative MTZs in the skin that extend into the dermis. This is achieved with mid infrared (2940 or 2790 nm) and far infrared (10,600 nm) lasers, which emit light that is strongly absorbed by water [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. A zone of thermally coagulated tissue also occurs around the ablated zone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/36/1610?source=see_link&amp;anchor=H7559191#H7559191\">",
"     \"Ablative laser resurfacing for skin rejuvenation\", section on 'Ablative fractional lasers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With the Er:YAG (2940 nm) laser, the peripheral coagulated zone is very narrow, which accounts for the frequent appearance of pinpoint bleeding during treatment. The CO2 (10,600 nm) laser yields a thicker coagulated zone, which reduces bleeding. However, the time required for reepithelialization is slightly longer with the CO2 laser. Reepithelialization usually occurs around four days after treatment with a fractionated Er:YAG laser and after about seven days following fractionated CO2 laser therapy. This relatively short time course to reepithelialization is an advantage over traditional laser resurfacing with pulsed CO2 or Er:YAG lasers, which requires a healing period of around 7 to 10 days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31999201\">",
"    <span class=\"h2\">",
"     Intense pulsed light",
"    </span>",
"    &nbsp;&mdash;&nbsp;IPL sources are filtered xenon flashlamps that release pulses of noncoherent polychromatic light. They are less powerful than lasers. &nbsp;",
"   </p>",
"   <p>",
"    Light emitted from IPL devices usually falls in the visible to near infrared range (400 to 1200 nm). The broad range of emitted light makes IPL sources versatile devices, allowing for treatment of both vascular and pigmented lesions. The primary use of IPL devices is for photorejuvenation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because the delivered light energy is spread over a broad range of wavelengths, greater numbers of treatment sessions usually are required for treatment with an IPL device than for treatment with lasers. Pulse durations are similar to the pulsed lasers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1638070\">",
"    <span class=\"h1\">",
"     OTHER LASER/LIGHT TISSUE INTERACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonthermal effects of lasers also are used for dermatologic indications. Excimer lasers optimize the localized delivery of narrowband ultraviolet B (UVB) light in phototherapy for psoriasis. In addition, lasers and IPL devices can be used to stimulate photochemical reactions in photodynamic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1638077\">",
"    <span class=\"h2\">",
"     Excimer laser",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 308 nm excimer laser delivers UVB light that is absorbed by proteins, DNA, and RNA in the skin. The laser works similarly to traditional narrowband UVB phototherapy in psoriasis, but allows for the delivery of higher doses of ultraviolet light to localized resistant plaques [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/30\">",
"     30",
"    </a>",
"    ]. The excimer laser has also been used for vitiligo and other dermatologic conditions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40042?source=see_link&amp;anchor=H26#H26\">",
"     \"Treatment of psoriasis\", section on 'Excimer laser'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=see_link&amp;anchor=H14#H14\">",
"     \"Vitiligo\", section on 'Excimer laser/lamp'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1638085\">",
"    <span class=\"h2\">",
"     Photodynamic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the dermatologic setting, photodynamic therapy typically involves the application of a topical photosensitizer (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/22/3428?source=see_link\">",
"     aminolevulinic acid",
"    </a>",
"    (ALA) or methyl-aminolevulinic acid) to a predetermined treatment site. After the photosensitizer has been absorbed into the tissue, the site is irradiated with a light source. Irradiation activates the photosensitizer, leading to a photochemical cascade that results in local cellular injury and death.",
"   </p>",
"   <p>",
"    Blue or red light-emitting diode (LED) sources, a variety of visible light lasers, and IPL devices all have been utilized as light sources for photodynamic therapy. Photodynamic therapy has been used for the treatment of actinic keratoses, skin cancer, and acne, as well as for photorejuvenation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22360/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment and prognosis of cutaneous squamous cell carcinoma\", section on 'Photodynamic therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H21#H21\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Photodynamic therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/54/33639?source=see_link&amp;anchor=H8#H8\">",
"     \"Light-based, adjunctive, and other therapies for acne vulgaris\", section on 'Light/laser therapies'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30968?source=see_link&amp;anchor=H519985#H519985\">",
"     \"Treatment of actinic keratosis\", section on 'Photodynamic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1638193\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lasers and intense pulsed light (IPL) devices are used to induce clinical changes in the skin through the manipulation of light energy. Lasers are powerful devices that deliver monochromatic, coherent, collimated beams of light. IPL devices are less powerful, filtered xenon flashlamps that deliver broadband, polychromatic, noncoherent light. An understanding of the interactions between light energy and skin is crucial for the safe and effective use of light-emitting devices. (See",
"      <a class=\"local\" href=\"#H31999019\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Light targeting the skin can be absorbed, scattered, reflected, or transmitted. Only light that is absorbed will exert a detectable clinical effect. (See",
"      <a class=\"local\" href=\"#H31999027\">",
"       'Skin optics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The theory of selective photothermolysis describes the use of light energy to selectively destroy specific structures in the skin while minimizing damage to other tissues. Most modern lasers used for dermatologic indications are designed to function through selective photothermolysis. (See",
"      <a class=\"local\" href=\"#H31999074\">",
"       'Selective photothermolysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The wavelength of emitted light determines its depth of penetration into the skin. In general, long wavelengths of light penetrate more deeply into the skin than shorter wavelengths. (See",
"      <a class=\"local\" href=\"#H31999082\">",
"       'Wavelength'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The thermal relaxation time of a target determines the ideal pulse duration for the delivery of light. If the pulse duration is equal to or shorter than the thermal relaxation time, heating and damage are confined to the target. If pulse durations longer than the thermal relaxation time are used, heat dissipates to surrounding tissues, and damage to the adjacent tissues may occur. (See",
"      <a class=\"local\" href=\"#H31999090\">",
"       'Pulse duration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Light delivered through a small spot size is more susceptible to scattering than light delivered through large spot sizes. Larger spot sizes are preferred when targeting structures in the mid or deep dermis. Spot size is less important for superficial targets. (See",
"      <a class=\"local\" href=\"#H31999113\">",
"       'Spot size'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cooling reduces collateral damage from laser or IPL treatment and enables the delivery of higher levels of light energy. Cooling agents may be cold gases, liquids, or solids. (See",
"      <a class=\"local\" href=\"#H31999161\">",
"       'Skin cooling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Examples of laser devices include continuous, quasi-continuous, pulsed, and fractionated lasers. Continuous and quasi-continuous lasers are infrequently used due to the increased risks of adverse effects secondary to excessive heating of tissue. Long-pulsed lasers allow for slow heating of targets, and are particularly effective for minimizing epidermal damage during laser hair removal. Q-switch lasers can deliver powerful, short pulses of light energy that shatter targets such as tattoo pigment in the dermis. Nonablative and ablative fractionated lasers create microscopic columns of coagulated or ablated tissue that are followed by reepithelialization and dermal remodeling. (See",
"      <a class=\"local\" href=\"#H31999169\">",
"       'Classification of devices'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/1\">",
"      GOLDMAN L, BLANEY DJ, KINDEL DJ Jr, FRANKE EK. Effect of the laser beam on the skin. Preliminary report. J Invest Dermatol 1963; 40:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/2\">",
"      GOLDMAN L, BLANEY DJ, KINDEL DJ Jr, et al. Pathology of the effect of the laser beam on the skin. Nature 1963; 197:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/3\">",
"      GOLDMAN L, WILSON RG, HORNBY P, MEYER RG. RADIATION FROM A Q-SWITCHED RUBY LASER. EFFECT OF REPEATED IMPACTS OF POWER OUTPUT OF 10 MEGAWATTS ON A TATTOO OF MAN. J Invest Dermatol 1965; 44:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/4\">",
"      Maiman T. Stimulated optical radiation in ruby. Nature 1960; 187:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/5\">",
"      Apfelberg DB, Maser MR, Lash H. Extended clinical use of the argon laser for cutaneous lesions. Arch Dermatol 1979; 115:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/6\">",
"      Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/7\">",
"      Tan OT, Murray S, Kurban AK. Action spectrum of vascular specific injury using pulsed irradiation. J Invest Dermatol 1989; 92:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/8\">",
"      Dierickx CC, Casparian JM, Venugopalan V, et al. Thermal relaxation of port-wine stain vessels probed in vivo: the need for 1-10-millisecond laser pulse treatment. J Invest Dermatol 1995; 105:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/9\">",
"      Dover JS, Margolis RJ, Polla LL, et al. Pigmented guinea pig skin irradiated with Q-switched ruby laser pulses. Morphologic and histologic findings. Arch Dermatol 1989; 125:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/10\">",
"      Babilas P, Shafirstein G, B&auml;umler W, et al. Selective photothermolysis of blood vessels following flashlamp-pumped pulsed dye laser irradiation: in vivo results and mathematical modelling are in agreement. J Invest Dermatol 2005; 125:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/11\">",
"      Arndt KA. Argon laser therapy of small cutaneous vascular lesions. Arch Dermatol 1982; 118:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/12\">",
"      Craig RD, Purser JM, Lessells AM, Hufton AP. Argon laser therapy for cutaneous lesions. Br J Plast Surg 1985; 38:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/13\">",
"      Lowe NJ, Lask G, Griffin ME, et al. Skin resurfacing with the Ultrapulse carbon dioxide laser. Observations on 100 patients. Dermatol Surg 1995; 21:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/14\">",
"      Teikemeier G, Goldberg DJ. Skin resurfacing with the erbium:YAG laser. Dermatol Surg 1997; 23:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/15\">",
"      Lu SY, Lee CC, Wu YY. Hair removal by long-pulse alexandrite laser in oriental patients. Ann Plast Surg 2001; 47:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/16\">",
"      Nelson JS, Berns MW. Basic laser physics and tissue interactions. Contemporary Dermatology 1988; 2:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/17\">",
"      Manstein D, Herron GS, Sink RK, et al. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/18\">",
"      Svaasand LO, Nelson JS. On the physics of laser-induced selective photothermolysis of hair follicles: Influence of wavelength, pulse duration, and epidermal cooling. J Biomed Opt 2004; 9:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/19\">",
"      Chang CJ, Nelson JS. Cryogen spray cooling and higher fluence pulsed dye laser treatment improve port-wine stain clearance while minimizing epidermal damage. Dermatol Surg 1999; 25:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/20\">",
"      Lask G, Keller G, Lowe N, Gormley D. Laser skin resurfacing with the SilkTouch flashscanner for facial rhytides. Dermatol Surg 1995; 21:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/21\">",
"      Khoury JG, Saluja R, Goldman MP. Comparative evaluation of long-pulse alexandrite and long-pulse Nd:YAG laser systems used individually and in combination for axillary hair removal. Dermatol Surg 2008; 34:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/22\">",
"      B&auml;umler W, Eibler ET, Hohenleutner U, et al. Q-switch laser and tattoo pigments: first results of the chemical and photophysical analysis of 41 compounds. Lasers Surg Med 2000; 26:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/23\">",
"      Fincher EF, Gladstone HB. Use of a dual-mode erbium:YAG laser for the surgical correction of rhinophyma. Arch Facial Plast Surg 2004; 6:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/24\">",
"      Orenstein A, Goldan O, Weissman O, et al. A new modality in the treatment of actinic cheilitis using the Er:YAG laser. J Cosmet Laser Ther 2007; 9:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/25\">",
"      Kono T, Chan HH, Groff WF, et al. Prospective direct comparison study of fractional resurfacing using different fluences and densities for skin rejuvenation in Asians. Lasers Surg Med 2007; 39:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/26\">",
"      Sherling M, Friedman PM, Adrian R, et al. Consensus recommendations on the use of an erbium-doped 1,550-nm fractionated laser and its applications in dermatologic laser surgery. Dermatol Surg 2010; 36:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/27\">",
"      Hunzeker CM, Weiss ET, Geronemus RG. Fractionated CO2 laser resurfacing: our experience with more than 2000 treatments. Aesthet Surg J 2009; 29:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/28\">",
"      Mahmoud BH, Srivastava D, Janiga JJ, et al. Safety and efficacy of erbium-doped yttrium aluminum garnet fractionated laser for treatment of acne scars in type IV to VI skin. Dermatol Surg 2010; 36:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/29\">",
"      Sadick NS, Weiss R, Kilmer S, Bitter P. Photorejuvenation with intense pulsed light: results of a multi-center study. J Drugs Dermatol 2004; 3:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/30\">",
"      Asawanonda P, Anderson RR, Chang Y, Taylor CR. 308-nm excimer laser for the treatment of psoriasis: a dose-response study. Arch Dermatol 2000; 136:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/31\">",
"      Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol 2005; 4:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22360/abstract/32\">",
"      Kawada A, Aragane Y, Kameyama H, et al. Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. J Dermatol Sci 2002; 30:129.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13648 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-05EE575892-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22360=[""].join("\n");
var outline_f21_53_22360=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1638193\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31999019\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31999027\">",
"      SKIN OPTICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31999074\">",
"      SELECTIVE PHOTOTHERMOLYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1638142\">",
"      THERAPEUTIC PARAMETERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31999082\">",
"      Wavelength",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31999090\">",
"      Pulse duration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2286663\">",
"      - Thermal relaxation time",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2286670\">",
"      - Large versus small structures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31999097\">",
"      Fluence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31999105\">",
"      Irradiance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31999113\">",
"      Spot size",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31999121\">",
"      FRACTIONAL PHOTOTHERMOLYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31999161\">",
"      SKIN COOLING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31999169\">",
"      CLASSIFICATION OF DEVICES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31999177\">",
"      Continuous and quasi-continuous wave lasers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31999185\">",
"      Pulsed lasers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31999193\">",
"      Fractionated lasers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5099189\">",
"      - Nonablative",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5099204\">",
"      - Ablative",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31999201\">",
"      Intense pulsed light",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1638070\">",
"      OTHER LASER/LIGHT TISSUE INTERACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1638077\">",
"      Excimer laser",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1638085\">",
"      Photodynamic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1638193\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13648\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13648|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/32/34308\" title=\"figure 1\">",
"      Light and skin interaction in laser therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/34/22048\" title=\"figure 2\">",
"      Chromophore absorption spectrum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/8/15502\" title=\"figure 3\">",
"      Electromagnetic spectrum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/30/44516\" title=\"figure 4\">",
"      Laser penetration into skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/29/24017\" title=\"figure 5\">",
"      Thermal relaxation time in skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/21/6493\" title=\"figure 6\">",
"      Fluence formula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/28/36300\" title=\"figure 7\">",
"      Irradiance formula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/15/39153\" title=\"figure 8\">",
"      Fractionated photothermolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13648|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/33/29211\" title=\"table 1\">",
"      Skin chromophores",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/25/10651\" title=\"table 2\">",
"      Skin thermal relaxation time",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/7/31869\" title=\"table 3\">",
"      Lasers in dermatology",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/36/1610?source=related_link\">",
"      Ablative laser resurfacing for skin rejuvenation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/25/32151?source=related_link\">",
"      Basic principles of medical lasers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/9/9370?source=related_link\">",
"      Laser and light therapy for cutaneous hyperpigmentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17146?source=related_link\">",
"      Laser and light therapy for cutaneous vascular lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/54/33639?source=related_link\">",
"      Light-based, adjunctive, and other therapies for acne vulgaris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=related_link\">",
"      Treatment and prognosis of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=related_link\">",
"      Treatment and prognosis of cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30968?source=related_link\">",
"      Treatment of actinic keratosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40042?source=related_link\">",
"      Treatment of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=related_link\">",
"      Vitiligo",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_53_22361="Acute liver failure caused by halothane anesthesia";
var content_f21_53_22361=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Acute liver failure caused by halothane anesthesia (low power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 332px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Most of the parenchyma has been destroyed and is replaced by lipofuscin-filled macrophages. The only visible hepatocytes are in the periportal areas, although they are swollen and clearly necrotic. There is total destruction of hepatocytes in the pericentral zones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22361=[""].join("\n");
var outline_f21_53_22361=null;
var title_f21_53_22362="Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis";
var content_f21_53_22362=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22362/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22362/contributors\">",
"     Richard D deShazo, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22362/contributors\">",
"     Stephen F Kemp, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22362/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22362/contributors\">",
"     Jonathan Corren, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/53/22362/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/53/22362/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/53/22362/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H896753\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic rhinitis, or allergic rhinosinusitis, is characterized by paroxysms of sneezing, rhinorrhea, and nasal obstruction, often accompanied by itching of the eyes, nose, and palate. Postnasal drip, cough, irritability, and fatigue are other common symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some investigators prefer the term rhinosinusitis to the separate terms rhinitis and sinusitis. This is because the nose and sinus mucosa are contiguous, rhinitis and sinusitis frequently occur together, rhinitis commonly leads to sinusitis, and nasal symptoms are common with sinusitis. However, within this topic review, rhinitis and sinusitis are referred to separately, given that management issues may differ for each condition and detailed reviews of acute and chronic sinusitis are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/15/2297?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations, epidemiology, and diagnosis of allergic rhinitis are presented in this topic review. The pathogenesis and treatment of this condition are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6775?source=see_link\">",
"     \"Pathogenesis of allergic rhinitis (rhinosinusitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37834?source=see_link\">",
"     \"Pharmacotherapy of allergic rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H897169\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic rhinitis is common, affecting 10 to 30 percent of children and adults in the United States and other industrialized countries [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/4-9\">",
"     4-9",
"    </a>",
"    ]. It may be less common in some parts of the world, although even developing countries report significant rates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/10-16\">",
"     10-16",
"    </a>",
"    ]. The prevalence of asthma, rhinoconjunctivitis, and eczema were systematically evaluated in approximately 1.2 million children in 98 countries in the International Study of Asthma and Allergies in Childhood (ISAAC) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/17\">",
"     17",
"    </a>",
"    ]. The overall prevalence of rhinoconjunctivitis in children aged 6 to 7 years and 13 to 14 years was 8.5 and 14.6 percent, respectively.",
"   </p>",
"   <p>",
"    The prevalence in the industrialized world is increasing, particularly in urban areas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. Theories about the reasons for increasing prevalence are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/43/19129?source=see_link\">",
"     \"Increasing prevalence of asthma and allergic rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H897183\">",
"    <span class=\"h2\">",
"     Economic burden",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic rhinitis is associated with significant morbidity and expense [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/21-24\">",
"     21-24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It accounts for at least 2.5 percent of all clinician visits, 2 million lost school days per year, 6 million lost work days, and 28 million restricted work days per year.",
"     </li>",
"     <li>",
"      The average number of annual prescriptions for patients with allergic rhinitis is nearly double that for patients without allergic rhinitis (19 versus 10) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Studies performed in the years around 2000 reported 2.4 billion American dollars spent on prescription and over-the-counter medications and $1.1 billion in clinician billings, causing a total indirect and direct cost of several billion dollars per year [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/25-27\">",
"       25-27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is evidence that the economic burden is increasing, at least in the United States. Medical spending to treat allergic rhinitis almost doubled from 2000 to 2005 (6.1 to 11.2 billion dollars) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/28\">",
"     28",
"    </a>",
"    ]. In addition to costs directly attributable to allergic rhinitis, the disorder is highly associated with asthma and sinusitis, further expanding its economic impact.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H897849\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following are proposed or identified risk factors for allergic rhinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Family history of atopy (ie, the genetic predisposition to develop allergic diseases)",
"     </li>",
"     <li>",
"      Male sex",
"     </li>",
"     <li>",
"      Birth during the pollen season",
"     </li>",
"     <li>",
"      Firstborn status",
"     </li>",
"     <li>",
"      Early use of antibiotics",
"     </li>",
"     <li>",
"      Maternal smoking exposure in the first year of life",
"     </li>",
"     <li>",
"      Exposure to indoor allergens, such as dust mite allergen",
"     </li>",
"     <li>",
"      Serum IgE &gt;100",
"      <span class=\"nowrap\">",
"       IU/mL",
"      </span>",
"      before age six",
"     </li>",
"     <li>",
"      Presence of allergen specific IgE",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A review of multiple studies reported that the presence of each of these factors was associated with a positive likelihood ratio for the diagnosis that ranged from three to five [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6775?source=see_link\">",
"     \"Pathogenesis of allergic rhinitis (rhinosinusitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H897856\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H897864\">",
"    <span class=\"h2\">",
"     Signs and symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic rhinitis presents with paroxysms of sneezing, rhinorrhea, nasal obstruction, and nasal itching. Postnasal drip, cough, irritability, and fatigue are other common symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Some patients experience itching of the palate and inner ear. Those with concomitant allergic conjunctivitis report bilateral itching, tearing,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    burning of the eyes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/2/34856?source=see_link&amp;anchor=H2#H2\">",
"     \"Allergic conjunctivitis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Young children typically do not blow their noses, and instead, may repeatedly snort, sniff, cough, and clear their throats. Some scratch their itchy palates with their tongues, producing a clicking sound (palatal click).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7950367\">",
"    <span class=\"h3\">",
"     Quality of life and cognitive function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep disturbed breathing is one of the most important sequelae of untreated allergic rhinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Fatigue and generalized malaise are common, although patients rarely report these symptoms directly [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Allergic rhinitis is associated with a host of cognitive and psychiatric issues in children and adolescents, including attention deficit hyperactivity disorder, lower exam scores during peak pollen seasons, poor concentration, impaired athletic performance, and low self-esteem [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/8,37-40\">",
"     8,37-40",
"    </a>",
"    ]. In adults, allergic rhinitis is associated with anxiety, depression, reduced academic performance and work productivity (and lower than that of patients with asthma), impaired sexual performance, and lower quality of life scores [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/10,35,41-44\">",
"     10,35,41-44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7949595\">",
"    <span class=\"h3\">",
"     Patterns of symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic rhinitis may be classified by temporal pattern (intermittent or persistent) and by severity (mild or moderate-severe) (",
"    <a class=\"graphic graphic_table graphicRef85849 \" href=\"UTD.htm?28/47/29435\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/45\">",
"     45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intermittent &mdash; Symptoms are present less than four days per week or for less than four weeks",
"     </li>",
"     <li>",
"      Persistent &mdash; Symptoms are present more than four days per week and for more than four weeks",
"     </li>",
"     <li>",
"      Mild &mdash; None of the items listed below for \"moderate-severe\" are present",
"     </li>",
"     <li>",
"      Moderate-severe &mdash; One or more of the following items is present:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Sleep disturbance",
"     </li>",
"     <li>",
"      Impairment of school or work performance",
"     </li>",
"     <li>",
"      Impairment of daily activities, leisure",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      sport activities",
"     </li>",
"     <li>",
"      Troublesome symptoms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This classification system was proposed by an international workshop of 34 specialists in respiratory allergy, in collaboration with the World Health Organization (WHO) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/45\">",
"     45",
"    </a>",
"    ]. The WHO had targeted allergic rhinitis because of its impact on asthma and mirrors the consensus asthma guidelines.",
"   </p>",
"   <p>",
"    Other commonly used terms are &ldquo;seasonal&rdquo;, which is allergic rhinitis that occurs at a particular time of the year (",
"    <a class=\"graphic graphic_figure graphicRef74234 \" href=\"UTD.htm?26/61/27615\">",
"     figure 1",
"    </a>",
"    ), and &ldquo;perennial,&rdquo; which describes symptoms to allergens that are present year round [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/46\">",
"     46",
"    </a>",
"    ]. This system of classification is preferred by the US Food and Drug Administration (FDA).",
"   </p>",
"   <p>",
"    Patients whose symptoms occur episodically are often more aware of the disability caused by allergic rhinitis, whereas patients with chronic symptoms often adapt to significant impairment over time, and may not seek medical care until symptoms become severe [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/39,40,47,48\">",
"     39,40,47,48",
"    </a>",
"    ]. Children, in particular, will endure significant disability.",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Persistent/perennial",
"    </span>",
"    symptoms are more common than purely intermittent or seasonal symptoms, although many patients have perennial symptoms with seasonal exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Seasonal allergy rhinitis is usually caused by pollen from trees, grasses, and weeds. Depending upon the geographic area, pollination periods for certain types of plants are well known (",
"    <a class=\"graphic graphic_figure graphicRef74234 \" href=\"UTD.htm?26/61/27615\">",
"     figure 1",
"    </a>",
"    ). Colloquial names sometimes correctly identify the triggering pollen (eg, cedar fever), although in other cases, a plant that is not causing symptoms but is very visible at the same time is implicated by the name (eg, rose fever, which refers to allergic rhinitis caused by grasses that pollinate at the same time that roses bloom, or hayfever, which occurs in the fall when hay is being gathered, but is caused by weed pollens or from mold growing in the hay). Symptoms of seasonal allergic rhinitis are predictable and reproducible from year to year.",
"   </p>",
"   <p>",
"    Perennial allergic rhinitis usually reflects allergy to indoor allergens like dust mites, cockroaches, mold spores, or animal dander, although aeroallergens may cause perennial rhinitis in tropical or subtropical climates. Perennial rhinitis due to outdoor allergens is common in subtropical regions with long pollinating seasons and ever present mold and dust mite allergens, and with occupational allergen exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/48/7945?source=see_link\">",
"     \"Occupational rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is important to understand that allergic rhinitis, whether seasonal or perennial, may be difficult to distinguish clinically from the nonallergic forms of rhinitis, since not all seasonal and perennial symptoms are unique to allergic forms of rhinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. As an example, chronic nonallergic rhinitis can be triggered by changes in weather and temperature, and may appear to have a seasonal pattern in some patients. Thus, for an accurate diagnosis of allergic rhinitis, diagnostic testing may be required. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Allergen-specific testing'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=see_link\">",
"     \"Chronic nonallergic rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7950557\">",
"    <span class=\"h3\">",
"     Increasing sensitivity over time",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a patient is continually exposed to an allergen, persistent nasal mucosal inflammation develops. In such patients, symptoms of rhinitis occur on exposure to lower doses of allergen (priming) and to nonspecific irritants (hyperreactivity). Clinically, this results in continued and frequently more severe rhinitis symptoms with exposure to low allergen concentrations. This phenomenon of increasing sensitivity over time probably results from a lowering of the threshold for a clinical response. Sequential allergen challenges in patients with allergic rhinitis result in more symptoms and higher levels of histamine and inflammatory cells in nasal washes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/52\">",
"     52",
"    </a>",
"    ]. Presumably, the induced inflammation recruits additional inflammatory cells and their products into the process, producing increasing symptoms.",
"   </p>",
"   <p>",
"    Concomitant with allergen priming, the nose becomes progressively more sensitive to cholinomimetic stimuli, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    and histamine, as well as irritant stimuli like cold air [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/53\">",
"     53",
"    </a>",
"    ]. Over time, many patients with allergic rhinitis report heightened sensitivity to irritants (eg, tobacco smoke, particulate pollution), volatile substances, and strong scents and perfumes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7950204\">",
"    <span class=\"h2\">",
"     Physical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following physical findings may be present in patients with active allergic rhinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/55\">",
"     55",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infraorbital edema and darkening due to subcutaneous venodilation, findings that are sometimes referred to as \"allergic shiners\"",
"     </li>",
"     <li>",
"      Accentuated lines or folds below the lower lids (Dennie-Morgan lines), which suggests concomitant allergic conjunctivitis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/2/34856?source=see_link\">",
"       \"Allergic conjunctivitis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      A transverse nasal crease caused by repeated rubbing and pushing the tip of the nose up with the hand (the \"allergic salute\")",
"     </li>",
"     <li>",
"      \"Allergic facies,\" which are typically seen in children with early-onset allergic rhinitis, consist of a highly arched palate, open mouth due to mouth breathing, and dental malocclusion (",
"      <a class=\"graphic graphic_picture graphicRef66393 \" href=\"UTD.htm?22/39/23152\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The internal structures of the nose, oropharynx, and ears should be examined:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The nasal mucosa of patients with active allergic rhinitis frequently has a pale bluish hue or pallor along with turbinate edema",
"     </li>",
"     <li>",
"      Clear rhinorrhea may be visible anteriorly, or if the nasal passages are obstructed, rhinorrhea may be visible dripping down the posterior pharynx",
"     </li>",
"     <li>",
"      Hyperplastic lymphoid tissue lining the posterior pharynx, which resembles cobblestones (a finding called &ldquo;cobblestoning&rdquo;)",
"     </li>",
"     <li>",
"      Serous fluid may accumulate behind tympanic membranes in patients with significant nasal mucosal swelling and eustachian tube dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/56\">",
"       56",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7950282\">",
"    <span class=\"h2\">",
"     Routine laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratories are usually normal. Neither peripheral blood eosinophil counts nor total serum IgE levels (elevated in only 30 to 40 percent of patients) are sensitive enough to help diagnose allergic rhinitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/22/30056?source=see_link&amp;anchor=H3927919#H3927919\">",
"     \"The relationship between IgE and allergic disease\", section on 'Allergic rhinitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3324263\">",
"    <span class=\"h2\">",
"     Natural history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic rhinitis typically requires a few years of allergen exposure to develop. Accordingly, it is uncommon in children under two years of age. If a very young child appears to have persistent nasal symptoms, other disorders should be considered. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Sensitization to aeroallergens generally precedes the appearance of rhinitis symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/57\">",
"     57",
"    </a>",
"    ]. Sensitization describes the presence of allergen-specific IgE, as measured by skin testing or in vitro tests. However, sensitization is not synonymous with allergy, and a person can be sensitized to an allergen without developing symptoms when exposed to that allergen. Only a subset of sensitized individuals demonstrate clinical allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/58\">",
"     58",
"    </a>",
"    ]. The distinction between sensitization and clinical allergy is discussed in more detail elsewhere (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/22/30056?source=see_link&amp;anchor=H1366655#H1366655\">",
"     \"The relationship between IgE and allergic disease\", section on 'Sensitization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In children, sensitization and then clinical allergy develop first to allergens that are continually present in the environment (eg, dust mites or animal danders) and then to pollens and other seasonal allergens. In a study of approximately 600 children, at least two seasons of pollen exposure were required before most children developed allergic symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After the age of two, the prevalence of allergic rhinitis steadily increases, demonstrating a bimodal peak in the early school and early adult years. In a prospective study of 2024 children, the prevalence of allergic rhinitis increased from 5 percent at the age of four years, to 14 percent at age eight [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/57\">",
"     57",
"    </a>",
"    ]. The prevalence then gradually increases, peaking in early adulthood. The condition is usually persistent throughout adulthood, with some improvement in older age [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/18,21,60-66\">",
"     18,21,60-66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Allergic rhinitis uncommonly presents for the first time in older adults, unless there is a significant change in exposures (eg, a new pet or a move to a different climate). Thus, in an older adult with new nasal symptoms, other causes of rhinitis should be considered. A change in response to treatment in older adults may indicate the development of vasomotor or atrophic rhinitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18519?source=see_link\">",
"     \"Atrophic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H897892\">",
"    <span class=\"h1\">",
"     ASSOCIATED CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic rhinitis occurs in association with a number of other disorders, including allergic conjunctivitis, acute or chronic sinusitis, asthma, and atopic dermatitis (eczema).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Allergic conjunctivitis",
"      </strong>",
"      : Up to 60 percent of patients with allergic rhinitis have concomitant allergic conjunctivitis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/67\">",
"       67",
"      </a>",
"      ]. Allergic conjunctivitis presents with itching, tearing, conjunctival edema, hyperemia, watery discharge, burning, and photophobia (",
"      <a class=\"graphic graphic_picture graphicRef57240 \" href=\"UTD.htm?14/20/14670\">",
"       picture 2",
"      </a>",
"      ). Eyelid edema is also common. Symptoms are usually bilateral. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/2/34856?source=see_link\">",
"       \"Allergic conjunctivitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Sinusitis",
"      </strong>",
"      : Nasal inflammation associated with allergic rhinitis can also cause obstruction of the sinus ostiomeatal complex, thereby predisposing to bacterial infection of the sinuses. This process accounts for as much as 30 to 80 percent of cases of acute and chronic bacterial sinusitis, respectively. However, purulent sinusitis without concurrent rhinitis is rare, given that these tissues are anatomically contiguous [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/68\">",
"       68",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Symptoms of bacterial sinusitis include nasal congestion, purulent rhinorrhea or postnasal drip, facial or dental pain, and cough. Purulent rhinorrhea, purulent postnasal drip, or pain in a maxillary tooth and persistent cough in children are the most useful predictors of bacterial sinusitis. However, no single symptom has a high degree of sensitivity or specificity in discriminating bacterial sinusitis from allergic or viral rhinitis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/69,70\">",
"       69,70",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link\">",
"       \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link&amp;anchor=H2#H2\">",
"       \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\", section on 'Anatomy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Asthma",
"      </strong>",
"      : Up to 50 percent of patients with asthma have allergic rhinitis. In children, cough and wheeze are the most common symptoms, and are often more prominent with exertion (",
"      <a class=\"graphic graphic_table graphicRef79182 \" href=\"UTD.htm?0/29/476\">",
"       table 2",
"      </a>",
"      ). Adults may report any combination of cough, wheeze, or chest tightness. The relationships between asthma and allergic rhinitis are discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/18/20776?source=see_link\">",
"       \"Relationships between rhinosinusitis and asthma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19653?source=see_link\">",
"       \"Epidemiology of asthma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26010?source=see_link\">",
"       \"Chronic asthma in children younger than 12 years: Evaluation and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=see_link\">",
"       \"Diagnosis of asthma in adolescents and adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Atopic dermatitis (eczema)",
"      </strong>",
"      : In children, atopic dermatitis presents with intensely pruritic erythematous patches with papules and some crusting, usually affecting the face, scalp, extremities, or trunk, with sparing of the diaper areas.",
"      <br/>",
"      <br/>",
"      In older individuals with more chronic disease, atopic dermatitis presents with thickened skin, increased skin markings (lichenification), and excoriated and fibrotic papules. The flexural areas (neck, antecubital fossae, and popliteal fossae) are most commonly involved in adults. This disorder is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Oral allergy syndrome",
"      </strong>",
"      : Oral allergy syndrome is a form of food allergy that develops in individuals who are sensitized to pollens. Patients report itching",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      mild swelling of the mouth and throat immediately following ingestion of certain uncooked fruits (such as apples, peaches, plums, cherries, and some nuts) or raw vegetables. The symptoms result from contact urticaria in the oropharynx caused by pollen-related proteins in these foods. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11082?source=see_link\">",
"       \"Clinical manifestations and diagnosis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37430?source=see_link\">",
"       \"Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Other conditions",
"      </strong>",
"      : Allergic rhinitis is strongly associated and probably causally related to eustachian tube dysfunction, causing concomitant serous and acute otitis media [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/56\">",
"       56",
"      </a>",
"      ]. Nasal obstruction due to severe allergic rhinitis can also cause sleep disordered breathing and anosmia [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/71-74\">",
"       71-74",
"      </a>",
"      ]. There may be an increased prevalence of migraine headache in patients with allergic rhinitis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/75\">",
"       75",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of allergic rhinitis can be made on",
"    <strong>",
"     clinical grounds",
"    </strong>",
"    based upon the presence of characteristic symptoms (ie, paroxysms of sneezing, rhinorrhea, nasal obstruction, nasal itching, postnasal drip, cough, irritability, and fatigue), a suggestive clinical history (including the presence of risk factors), and supportive findings on physical examination. Allergy skin testing confirms that the patient is sensitized to aeroallergens, although it is not necessary for the initial diagnosis.",
"   </p>",
"   <p>",
"    Imaging is not usually performed in the diagnosis of allergic rhinitis, unless a concomitant condition, such as chronic rhinosinusitis, is suspected or there is a history of facial trauma or features to suggest anatomic abnormalities (unilateral congestion or obstruction).",
"   </p>",
"   <p>",
"    If the patient&rsquo;s symptoms prove difficult to manage or the trigger(s) for the symptoms are not apparent, then further evaluation is indicated to demonstrate that the patient is sensitized to aeroallergens and that symptoms occur when expected for the allergens in question. Sensitization can be demonstrated with either allergy skin testing or in vitro tests for allergen-specific IgE. (See",
"    <a class=\"local\" href=\"#H3018812\">",
"     'When to refer'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A positive response to a therapeutic trial of either topical nasal steroids or topical antihistamines does not conclusively establish a diagnosis of allergic rhinitis, because these therapies are also effective in the treatment of nonallergic rhinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=see_link&amp;anchor=H13#H13\">",
"     \"Chronic nonallergic rhinitis\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some forms of allergic rhinitis can be readily diagnosed by history alone, while others may require additional evaluation for accurate diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seasonal allergic rhinitis is often diagnosed by the history alone, because it is reproducible from year to year. Seasonal allergic rhinitis caused by tree and grass pollen typically occurs in the spring, and symptoms caused by ragweed pollen exposure in the fall, although there are regional variations (",
"      <a class=\"graphic graphic_figure graphicRef74234 \" href=\"UTD.htm?26/61/27615\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Some cases of episodic allergic rhinitis can be diagnosed by history alone if there is an obvious connection between exposure and the onset of symptoms. As an example, a history of episodic exposure to animals or high levels of house dust resulting in acute allergic symptoms may be readily diagnosed as episodic allergic rhinitis.",
"     </li>",
"     <li>",
"      By comparison, the culprit allergens in",
"      <span class=\"nowrap\">",
"       perennial/persistent",
"      </span>",
"      allergic rhinitis may not be readily apparent from the clinical history. Perennial allergic rhinitis usually reflects allergy to indoor allergens like dust mites, cockroaches, or animal dander, although pollens may cause perennial rhinitis in tropical or subtropical climates.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H514441\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nose, oropharynx, tympanic membranes, and eyes should be examined, as each of these structures may show findings of allergic rhinitis or associated disorders. (See",
"    <a class=\"local\" href=\"#H7950204\">",
"     'Physical findings'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The internal structures of the nose and the nasal mucosa can be visualized using a standard office otoscope with a disposable tip. Stabilizing the tip against the patient&rsquo;s upper nares prevents painful prodding of the mucosa, which is normally exquisitely sensitive to touch.",
"   </p>",
"   <p>",
"    In patients older than five years of age, flexible fiberoptic rhinoscopy is helpful but not essential for diagnosis. If pursued, it should be performed by clinicians specifically trained in the technique. This technique is described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=see_link&amp;anchor=H23061096#H23061096\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\", section on 'Rhinoscopy and endoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Allergen-specific testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is not necessary to perform testing for allergen-specific IgE, either with blood tests or skin testing, before making the presumptive diagnosis of allergic rhinitis and initiating treatment. Primary care clinicians treat the majority of patients with allergic rhinitis, and often initiate therapy empirically, identifying possible triggers only through the clinical history. This approach is adequate for many patients.",
"   </p>",
"   <p>",
"    Despite the above, the use of diagnostic testing to identify culprit allergens has been associated with improved patient outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/78\">",
"     78",
"    </a>",
"    ]. Identifying the allergens that are important to an individual facilitates avoidance of the allergen and identifies candidates for allergen immunotherapy, which can eventually reduce reliance on chronic medications.",
"   </p>",
"   <p>",
"    Properly performed skin testing is the most convenient, sensitive, and least expensive screening method to detect allergic sensitization [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/79\">",
"     79",
"    </a>",
"    ]. Skin testing is usually performed by allergy experts because, although generally considered a safe technique, rare systemic allergic reactions are possible in response to the testing itself.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15264438\">",
"    <span class=\"h3\">",
"     Skin testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediate hypersensitivity skin testing (prick skin tests) is a quick, cost effective, and safe way to identify the presence of allergen-specific IgE [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. These tests are usually performed by allergy specialists. In sensitive patients, testing with selected diagnostic solutions of tree, grass, or weed pollen, mold, house dust mite,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    animal allergens results in a wheal and flare reaction at the skin test site within 20 minutes. Positive prick skin tests correlate more closely with symptoms than intradermal tests. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32633?source=see_link\">",
"     \"Overview of skin testing for allergic disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Skin testing is particularly useful among patients with:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An unclear diagnosis based upon the history and physical examination",
"     </li>",
"     <li>",
"      Poorly controlled symptoms, such as persistent nasal symptoms",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an inadequate clinical response to nasal glucocorticoids",
"     </li>",
"     <li>",
"      Coexisting persistent asthma",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      recurrent",
"      <span class=\"nowrap\">",
"       sinusitis/otitis",
"      </span>",
"     </li>",
"     <li>",
"      A high pre-test probability of allergic rhinitis and negative in vitro test results to suspected culprit allergens (because the sensitivity of skin testing is usually superior to that of in vitro testing)",
"     </li>",
"     <li>",
"      A patient&rsquo;s expressed desire to try to avoid the allergen rather than take medications to control symptoms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Skin testing a very symptomatic pollen-allergic patient during peak pollen season should be avoided, as it can aggravate symptoms further and may be associated with higher rates of systemic reactions during testing. In this setting, the patient's symptoms should be treated empirically and testing should be deferred until the patient is less symptomatic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Serum tests for allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunoassays to detect allergen-specific IgE antibodies in the serum have limited utility in the diagnosis of allergic rhinitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/79\">",
"     79",
"    </a>",
"    ]. These tests are sometimes referred to as radioallergosorbent tests, or RASTs, because earlier methods utilized radioactive reagents. The methods currently in use are more correctly referred to as immunoassays for allergen-specific IgE.",
"   </p>",
"   <p>",
"    IgE immunoassays provide similar information as that obtained with allergen skin tests, although they are more expensive and less sensitive for the diagnosis of allergy to inhalant allergens, compared with skin tests. The precise sensitivity of IgE immunoassays, compared to skin prick testing, has been reported to range from less than 50 percent to more than 90 percent, with the average being 70 to 75 percent in most studies. Similar sensitivity ranges apply when immunoassay results were compared with symptoms induced during natural or controlled target organ challenge procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/81\">",
"     81",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/22/44391?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of in vitro allergy tests\", section on 'Accuracy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The utility of screening panels of IgE immunoassays has been evaluated in the diagnosis of allergic rhinitis. Such testing can improve diagnostic accuracy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    management, when skin testing is not available [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/82-84\">",
"     82-84",
"    </a>",
"    ]. These panels typically test for IgE antibodies to common seasonal and perennial allergens, and are intended for use by generalists [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/80\">",
"     80",
"    </a>",
"    ]. However, this approach can be costly if excessive numbers of immunoassays are measured, or if the allergens selected are not relevant to the geographic area in question. A logical approach would involve consulting an allergy expert in the area initially to identify a small number of important allergens for the area (eg, a few prominent pollens, animal danders, molds for dry environments and dust mites for humid environments) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5649703\">",
"    <span class=\"h3\">",
"     Suggestive history with negative testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally, a patient presents with a history and physical findings suggestive of allergic rhinitis, but skin testing and in vitro testing are negative. Most commonly, such patients have chronic nonallergic rhinitis, which has subtly different historical features and physical findings, as reviewed below. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Another possibility is that the patient is producing allergen-specific IgE locally in the nasal tissues, but it is not reflected in the systemic circulation or skin. This condition is sometimes referred to as &ldquo;local allergic rhinitis&rdquo; and it is an area of increasing research interest. Local allergic rhinitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=see_link&amp;anchor=H7#H7\">",
"     \"Chronic nonallergic rhinitis\", section on 'Evidence for a localized allergic response'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fortunately, patients with either of these disorders may be managed similarly to those with allergic rhinitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37834?source=see_link&amp;anchor=H25107621#H25107621\">",
"     \"Pharmacotherapy of allergic rhinitis\", section on 'Summary and recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7949995\">",
"    <span class=\"h2\">",
"     Uncommonly used tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal cytology and direct inhalational challenge with allergen are techniques that are largely limited to research settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9486750\">",
"    <span class=\"h3\">",
"     Nasal cytology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal cytology is performed by some investigators to help differentiate rhinitis due to allergy from that due to infection, although it is relatively nonspecific and insensitive. Nasal secretions may be obtained with a cotton swab, or by asking the patient to blow the nose onto waxed paper or cellophane. Wright stain of nasal secretions usually, but not always, reveals a predominance of eosinophils in cases of allergic rhinitis. By comparison, the presence of neutrophils suggests an infectious process.",
"   </p>",
"   <p>",
"    Nasal eosinophilia may also be seen in other conditions including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asthma without symptoms of nasal allergy",
"     </li>",
"     <li>",
"      Nasal polyposis, with or without asthma and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      sensitivity (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39944?source=see_link\">",
"       \"Aspirin exacerbated respiratory disease\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Nonallergic rhinitis with eosinophilia syndrome (NARES), a syndrome of marked nasal eosinophilia and a propensity for nasal polyps, but with negative allergic histories, negative skin tests, and no",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      sensitivity (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Differential diagnosis'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some also utilize nasal cytology to assess the response to antiinflammatory medications, thereby providing further support for a particular diagnosis. Eosinophilia, for example, should decrease with therapy in patients with allergic rhinitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9486757\">",
"    <span class=\"h3\">",
"     Allergen challenge",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although nasal allergen challenge can definitively establish the diagnosis, it is clinically impractical and rarely performed outside of research settings. Nasal challenge procedures are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=see_link&amp;anchor=H7#H7\">",
"     \"Chronic nonallergic rhinitis\", section on 'Evidence for a localized allergic response'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/48/7945?source=see_link\">",
"     \"Occupational rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H905774\">",
"    <span class=\"h2\">",
"     Unproven diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several unproven or inappropriate diagnostic testing assays that are being offered by various types of providers with increasing frequency. These include cytotoxic testing, provocation-neutralization testing, and specific or nonspecific IgG determinations [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/86\">",
"     86",
"    </a>",
"    ]. The results of these methods are",
"    <strong>",
"     not",
"    </strong>",
"    useful for diagnosis or management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3018812\">",
"    <span class=\"h1\">",
"     WHEN TO REFER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients whose symptoms are severe or refractory to therapy should be referred to an allergy specialist for a more definitive evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/87,88\">",
"     87,88",
"    </a>",
"    ]. Referral to an allergy or pulmonary specialist is also useful for patients with concomitant allergic rhinitis and asthma, and an otolaryngologist may be helpful in managing patients with recurrent episodes of sinusitis or otitis media.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various other disorders can mimic allergic rhinitis or coexist with it in older children and adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3645244\">",
"    <span class=\"h2\">",
"     Children under two years of age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because allergic sensitization takes a few years to develop, other disorders should be considered in very young children who have persistent rhinitis symptoms. (See",
"    <a class=\"local\" href=\"#H3324263\">",
"     'Natural history'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    These include adenoidal hypertrophy, acute or chronic sinusitis, congenital abnormalities (choanal atresia), foreign bodies, and nasal polyps. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11194?source=see_link&amp;anchor=H31#H31\">",
"     \"The pediatric physical examination: HEENT\", section on 'Nose'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3645251\">",
"    <span class=\"h2\">",
"     Older children and adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rhinitis can result from either inflammatory or noninflammatory causes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Acute infectious rhinitis",
"      </strong>",
"      : Symptoms of the common cold vary from patient to patient, with rhinitis and nasal congestion being the most common. Nasal obstruction, rhinorrhea, and sneezing are usually present early in the course of the cold, although a sore or \"scratchy\" throat is frequently the most bothersome symptom on the first day of illness. The sore throat is usually short lived, and nasal symptoms predominate by the second and third day. Cough typically becomes troublesome on the fourth or fifth day of illness, by which time the nasal symptoms are less severe. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/55/24440?source=see_link\">",
"       \"The common cold in adults: Diagnosis and clinical features\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Acute bacterial sinusitis develops in 0.5 to 2.5 percent of adult patients after viral upper respiratory tract infection. Viral sinusitis occurs much more frequently. The clinical presentation of the patient is of limited utility in distinguishing cases of pure viral rhinosinusitis from those with secondary bacterial infection. There appear to be",
"      <strong>",
"       no",
"      </strong>",
"      signs and symptoms of acute respiratory illness that are both sensitive and specific in making this distinction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link\">",
"       \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Symptoms",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      complaints of a common cold that last for more than two weeks may be confused with those due to allergic rhinitis. As previously mentioned, however, many patients commonly have both sinusitis and allergic rhinitis, a setting in which the diagnosis and treatment of both conditions must be entertained. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link\">",
"       \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The remaining disorders discussed below result from chronic processes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Chronic nonallergic rhinitis",
"      </strong>",
"      : Approximately 50 percent of patients with chronic rhinitis have a component of nonallergic rhinitis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/72,90\">",
"       72,90",
"      </a>",
"      ]. Chronic nonallergic rhinitis is characterized by perennial symptoms and mild or absent nasal itching and sneezing. Patients with this disorder complain of chronic nasal congestion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      rhinorrhea that is intensified by rapid changes in temperature and relative humidity, odors, or alcohol. They have little nasal itching or sneezing; however, headaches, anosmia, and sinusitis are common. A family history of allergy or allergic symptom triggers is uncommon. Negative skin tests to inhalant allergens are essentially diagnostic for a nonallergic rhinitis syndrome. Syndromes of nonallergic rhinitis include vasomotor rhinitis, gustatory rhinitis, and nonallergic rhinitis with nasal eosinophilia syndrome. These are reviewed in more detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=see_link\">",
"       \"Chronic nonallergic rhinitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Chronic rhinosinusitis",
"      </strong>",
"      : Chronic rhinosinusitis (CRS) is defined as an inflammatory condition involving the paranasal sinuses and linings of the nasal passages that lasts 12 weeks or longer, despite attempts at medical management. CRS can coexist with allergic rhinitis. The diagnosis of CRS requires any TWO of the following symptoms, present for at least 12 weeks:",
"      <br/>",
"      <br/>",
"      - Anterior",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      posterior mucopurulent drainage",
"      <br/>",
"      <br/>",
"      - Nasal obstruction",
"      <br/>",
"      <br/>",
"      - Facial pain, pressure,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      fullness",
"      <br/>",
"      <br/>",
"      - Decreased sense of smell",
"      <br/>",
"      <br/>",
"      Concomitant CRS should be considered when a patient with allergic rhinitis also has the above-mentioned symptoms and fails to improve with treatment for allergic rhinitis. The diagnosis of CRS is discussed in greater detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=see_link\">",
"       \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Rhinitis medicamentosa",
"      </strong>",
"      : Rhinitis medicamentosa is a complication of vasoconstrictor nasal sprays (which may develop with as little as five days of use) or intranasal cocaine abuse. Chronic nasal obstruction and nasal inflammation develop and are manifested as beefy red nasal membranes on physical examination. Diagnosis depends almost entirely on the appropriate history, characteristic physical examination findings, and positive response to treatment with topical nasal steroids, which is usually required to withdraw successfully from the culprit medication [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/91-93\">",
"       91-93",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=see_link&amp;anchor=H11252036#H11252036\">",
"       \"Chronic nonallergic rhinitis\", section on 'Medication-induced rhinitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Rhinitis due to systemic medications",
"      </strong>",
"      : A variety of systemic medications can induce nasal symptoms. This is in contrast to rhinitis medicamentosa, which is a specific syndrome that results from the intranasal application of certain drugs.",
"      <br/>",
"      <br/>",
"      Classes of medications that can cause nasal symptoms include birth control pills, antihypertensive drugs (alpha-adrenergic blockers, beta-adrenergic blockers, ACE inhibitors), erectile dysfunction drugs, and nonsteroidal antiinflammatory drugs. Psychiatric medications that have been implicated include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/38/30312?source=see_link\">",
"       chlorpromazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/35/32311?source=see_link\">",
"       thioridazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/49/19223?source=see_link\">",
"       perphenazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/36/4679?source=see_link\">",
"       chlordiazepoxide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"       amitriptyline",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/31/31224?source=see_link\">",
"       alprazolam",
"      </a>",
"      . Lastly, the immunosuppressants",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      and mycophenolic acid can cause nasal symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/94\">",
"       94",
"      </a>",
"      ]. Rhinitis symptoms caused by these medications generally subside within a few weeks of discontinuation.",
"     </li>",
"     <li>",
"      <strong>",
"       Atrophic rhinitis",
"      </strong>",
"      : Atrophic rhinitis is a syndrome of progressive atrophy of the nasal mucosa usually seen in elderly patients; such individuals report chronic nasal congestion and perceive a persistent bad odor. This condition is associated with mucosal colonization with Klebsiella ozaenae. A variant occurs in patients who have had multiple sinus surgeries resulting in loss of normal mucociliary function. This is discussed separately (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18519?source=see_link\">",
"       \"Atrophic rhinosinusitis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Rhinitis associated with hormonal changes",
"      </strong>",
"      : Rhinitis of pregnancy and rhinitis of hypothyroidism reflect nasal obstruction that occurs on a hormonal basis. In these settings, the diagnosis is clinical and is supported by negative skin tests or improved symptoms upon resolution or treatment of the causative condition. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32340?source=see_link\">",
"       \"Respiratory tract changes during pregnancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link\">",
"       \"Clinical manifestations of hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Unilateral rhinitis or nasal polyps",
"      </strong>",
"      : Unilateral rhinitis or nasal polyps are uncommon in uncomplicated allergic rhinitis. Unilateral rhinitis suggests the possibility of nasal obstruction by a foreign body, tumor, or polyp, and the presence of nasal polyps suggests NARES, chronic bacterial sinusitis, allergic fungal sinusitis,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      hypersensitivity, cystic fibrosis, or primary ciliary dyskinesia (immotile cilia syndrome). Fiberoptic rhinoscopy may be helpful in this setting. Increasing evidence also suggests that the histology of those with rhinitis with or without nasal polyps are different, with eosinophils or neutrophils predominating in those with or without polyps, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?21/53/22362/abstract/89\">",
"       89",
"      </a>",
"      ]. However, allergic rhinosinusitis and NARES are both conditions characterized by nasal eosinophilia, but most patients with these conditions lack nasal polyps. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=see_link\">",
"       \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8775?source=see_link\">",
"       \"Fungal rhinosinusitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=see_link\">",
"       \"Epidemiology and clinical manifestations of invasive aspergillosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=see_link\">",
"       \"Cystic fibrosis: Clinical manifestations and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Rhinitis with immunologic disorders",
"      </strong>",
"      : A number of systemic autoimmune disorders present with nasal symptoms or can affect nasal mucosa. These include granulomatosis with polyangiitis (Wegener&rsquo;s) and relapsing polychondritis:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The most common presenting symptoms of granulomatosis with polyangiitis include persistent rhinorrhea,",
"      <span class=\"nowrap\">",
"       purulent/bloody",
"      </span>",
"      nasal discharge, oral",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      nasal ulcers, polyarthralgias, myalgias, or sinus pain.",
"     </li>",
"     <li>",
"      With relapsing polychondritis, symptoms of stuffiness, crusting, rhinorrhea, and on occasion, epistaxis, may accompany nasal cartilage inflammation, which can also compromise olfaction. Cartilage destruction associated with sustained or recurrent episodes of inflammation can result in a characteristic saddle nose deformity.",
"      <br/>",
"      <br/>",
"      Such disorders may therefore present with nasal symptoms, without evidence of systemic disease. These disorders are diagnosed based upon the combination of characteristic histologic and clinical findings. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link\">",
"       \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/63/26616?source=see_link\">",
"       \"Clinical manifestations of relapsing polychondritis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/38/37474?source=see_link\">",
"       \"Patient information: Seasonal allergies in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/10/13475?source=see_link\">",
"       \"Patient information: Seasonal allergies in children (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/24/42370?source=see_link\">",
"       \"Patient information: Allergy skin testing (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/8/41092?source=see_link\">",
"       \"Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Allergic rhinitis is characterized by paroxysms of sneezing, rhinorrhea, nasal obstruction, post nasal drainage, and itching of the eyes, nose, and palate. More insidious effects of the disorder include fatigue, irritability, reduced performance at school and work, and depression. (See",
"      <a class=\"local\" href=\"#H896753\">",
"       'Introduction and terminology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H897856\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Allergic rhinitis affects 10 to 30 percent of children and adults in the United States. The prevalence is increasing in industrialized countries worldwide, particularly in urban areas. Although frequently underdiagnosed and undertreated, allergic rhinitis imposes a significant economic burden as a result of reduced school performance and work productivity, clinician visits, expense of over-the-counter and prescription medications, and cost of treating related conditions, such as sinusitis and asthma. (See",
"      <a class=\"local\" href=\"#H897169\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H897892\">",
"       'Associated conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Allergic rhinitis may be classified by temporal pattern (intermittent or persistent) and by severity (mild or moderate-severe) (",
"      <a class=\"graphic graphic_table graphicRef85849 \" href=\"UTD.htm?28/47/29435\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7949595\">",
"       'Patterns of symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of allergic rhinitis is made clinically, based upon a suggestive history (including presence of risk factors), characteristic symptoms and signs on physical examination, and (if indicated) the confirmed presence of allergen-specific IgE. Symptoms should also be reproducible (by history) upon exposure to allergens to which the patient is sensitized. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Identification of the specific allergens to which the patient is sensitive is not necessary for successful treatment in many cases. However, patients whose symptoms are severe or refractory to therapy should be referred to an allergy specialist for a more definitive evaluation. Properly performed skin testing is the best method for determining allergic sensitization. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Allergen-specific testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of allergic rhinitis includes acute and chronic rhinosinusitis, chronic nonallergic rhinitis, rhinitis medicamentosa, atrophic rhinitis, and rhinitis due to systemic medications. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/1\">",
"      Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/2\">",
"      Ng ML, Warlow RS, Chrishanthan N, et al. Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (I). Clin Exp Allergy 2000; 30:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/3\">",
"      Ng ML, Warlow RS, Chrishanthan N, et al. Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (II). Clin Exp Allergy 2000; 30:1417.",
"     </a>",
"    </li>",
"    <li>",
"     US Department of Health and Human Services. Agency for Healthcare Research and Quality. Management of allergic and nonallergic rhinitis. May 2002. AHQR publication 02:E023, Boston, MA. Summary, Evidence Report/Technology Assessment: No 54. file://www.ahrq.gov/clinic/epcsums/rhinsum.htm (Accessed on August 03, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/5\">",
"      Settipane RA. Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc 2001; 22:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/6\">",
"      Singh K, Axelrod S, Bielory L. The epidemiology of ocular and nasal allergy in the United States, 1988-1994. J Allergy Clin Immunol 2010; 126:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/7\">",
"      Wu WF, Wan KS, Wang SJ, et al. Prevalence, severity, and time trends of allergic conditions in 6-to-7-year-old schoolchildren in Taipei. J Investig Allergol Clin Immunol 2011; 21:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/8\">",
"      Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 2009; 124:S43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/9\">",
"      Abdulrahman H, Hadi U, Tarraf H, et al. Nasal allergies in the Middle Eastern population: results from the \"Allergies in Middle East Survey\". Am J Rhinol Allergy 2012; 26 Suppl 1:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/10\">",
"      Romano-Zelekha O, Graif Y, Garty BZ, et al. Trends in the prevalence of asthma symptoms and allergic diseases in Israeli adolescents: results from a national survey 2003 and comparison with 1997. J Asthma 2007; 44:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/11\">",
"      Lima RG, Pastorino AC, Casagrande RR, et al. Prevalence of asthma, rhinitis and eczema in 6 - 7 years old students from the western districts of S&atilde;o Paulo City, using the standardized questionnaire of the \"International Study of Asthma and Allergies in Childhood\" (ISAAC)-phase IIIB. Clinics (Sao Paulo) 2007; 62:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/12\">",
"      Kong WJ, Chen JJ, Zheng ZY, et al. Prevalence of allergic rhinitis in 3-6-year-old children in Wuhan of China. Clin Exp Allergy 2009; 39:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/13\">",
"      Abong JM, Kwong SL, Alava HD, et al. Prevalence of allergic rhinitis in Filipino adults based on the National Nutrition and Health Survey 2008. Asia Pac Allergy 2012; 2:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/14\">",
"      Zar HJ, Ehrlich RI, Workman L, Weinberg EG. The changing prevalence of asthma, allergic rhinitis and atopic eczema in African adolescents from 1995 to 2002. Pediatr Allergy Immunol 2007; 18:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/15\">",
"      Vichyanond P, Jirapongsananuruk O, Visitsuntorn N, Tuchinda M. Prevalence of asthma, rhinitis and eczema in children from the Bangkok area using the ISAAC (International Study for Asthma and Allergy in Children) questionnaires. J Med Assoc Thai 1998; 81:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/16\">",
"      Kabir ML, Rahman F, Hassan MQ, et al. Asthma, atopic eczema and allergic rhino-conjunctivitis in school children. Mymensingh Med J 2005; 14:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/17\">",
"      Mallol J, Crane J, von Mutius E, et al. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesis. Allergol Immunopathol (Madr) 2013; 41:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/18\">",
"      Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999; 82:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/19\">",
"      von Mutius E, Weiland SK, Fritzsch C, et al. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 1998; 351:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/20\">",
"      Sol&eacute; D, Cassol VE, Silva AR, et al. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among adolescents living in urban and rural areas in different regions of Brazil. Allergol Immunopathol (Madr) 2007; 35:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/21\">",
"      D'Alonzo GE Jr. Scope and impact of allergic rhinitis. J Am Osteopath Assoc 2002; 102:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/22\">",
"      Woods L, Craig TJ. The importance of rhinitis on sleep, daytime somnolence, productivity and fatigue. Curr Opin Pulm Med 2006; 12:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/23\">",
"      Schatz M, Zeiger RS, Chen W, et al. The burden of rhinitis in a managed care organization. Ann Allergy Asthma Immunol 2008; 101:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/24\">",
"      Bhattacharyya N. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States. Laryngoscope 2011; 121:1830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/25\">",
"      Torrance GW. Preferences for health outcomes and cost-utility analysis. Am J Manag Care 1997; 3 Suppl:S8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/26\">",
"      Ray NF, Baraniuk JN, Thamer M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol 1999; 103:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/27\">",
"      Bender BG. Cognitive effects of allergic rhinitis and its treatment. Immunol Allergy Clin North Am 2005; 25:301.",
"     </a>",
"    </li>",
"    <li>",
"     Soni A. Allergic rhinitis: trends in use and expenditures, 2000 to 2005. Statistical Brief #204, Agency for Healthcare Research and Quality; Bethesda, MD 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/29\">",
"      Matheson MC, Dharmage SC, Abramson MJ, et al. Early-life risk factors and incidence of rhinitis: results from the European Community Respiratory Health Study--an international population-based cohort study. J Allergy Clin Immunol 2011; 128:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/30\">",
"      Frew AJ. Advances in environmental and occupational diseases 2003. J Allergy Clin Immunol 2004; 113:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/31\">",
"      Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 91:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/32\">",
"      Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med 2004; 140:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/33\">",
"      Georgalas C. The role of the nose in snoring and obstructive sleep apnoea: an update. Eur Arch Otorhinolaryngol 2011; 268:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/34\">",
"      Koinis-Mitchell D, Craig T, Esteban CA, Klein RB. Sleep and allergic disease: a summary of the literature and future directions for research. J Allergy Clin Immunol 2012; 130:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/35\">",
"      Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 2009; 30:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/36\">",
"      Blaiss MS. Pediatric allergic rhinitis: physical and mental complications. Allergy Asthma Proc 2008; 29:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/37\">",
"      Brawley A, Silverman B, Kearney S, et al. Allergic rhinitis in children with attention-deficit/hyperactivity disorder. Ann Allergy Asthma Immunol 2004; 92:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/38\">",
"      Vuurman EF, van Veggel LM, Uiterwijk MM, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993; 71:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/39\">",
"      Marshall PS, O'Hara C, Steinberg P. Effects of seasonal allergic rhinitis on selected cognitive abilities. Ann Allergy Asthma Immunol 2000; 84:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/40\">",
"      Walker S, Khan-Wasti S, Fletcher M, et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 2007; 120:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/41\">",
"      L&eacute;ger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med 2006; 166:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/42\">",
"      Cuffel B, Wamboldt M, Borish L, et al. Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics 1999; 40:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/43\">",
"      Postolache TT, Lapidus M, Sander ER, et al. Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens. ScientificWorldJournal 2007; 7:1968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/44\">",
"      Benninger MS, Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc 2009; 30:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/45\">",
"      Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/46\">",
"      Scadding GK. Recent advances in the treatment of rhinitis and rhinosinusitis. Intern Congr Series 2003; 1254:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/47\">",
"      Kremer B, den Hartog HM, Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy 2002; 32:1310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/48\">",
"      Fineman SM. The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol 2002; 88:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/49\">",
"      Mullarkey MF, Hill JS, Webb DR. Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol 1980; 65:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/50\">",
"      Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001; 86:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/51\">",
"      Siracusa A, Desrosiers M, Marabini A. Epidemiology of occupational rhinitis: prevalence, aetiology and determinants. Clin Exp Allergy 2000; 30:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/52\">",
"      Wachs M, Proud D, Lichtenstein LM, et al. Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol 1989; 84:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/53\">",
"      Druce HM, Wright RH, Kossoff D, Kaliner MA. Cholinergic nasal hyperreactivity in atopic subjects. J Allergy Clin Immunol 1985; 76:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/54\">",
"      Sarin S, Undem B, Sanico A, Togias A. The role of the nervous system in rhinitis. J Allergy Clin Immunol 2006; 118:999.",
"     </a>",
"    </li>",
"    <li>",
"     Howarth PH. Allergic and nonallergic rhinitis. In: Middleton's allergy: Principles and practice, 6th ed, Adkinson NF, Yunginger JW, Busse WW, et al (Eds), Mosby, St. Louis 2003. p.1391.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/56\">",
"      Fireman P. Otitis media and eustachian tube dysfunction: connection to allergic rhinitis. J Allergy Clin Immunol 1997; 99:S787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/57\">",
"      Westman M, Stj&auml;rne P, Asarnoj A, et al. Natural course and comorbidities of allergic and nonallergic rhinitis in children. J Allergy Clin Immunol 2012; 129:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/58\">",
"      Blomme K, Tomassen P, Lapeere H, et al. Prevalence of allergic sensitization versus allergic rhinitis symptoms in an unselected population. Int Arch Allergy Immunol 2013; 160:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/59\">",
"      Kulig M, Klettke U, Wahn V, et al. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000; 106:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/60\">",
"      Dottorini ML, Bruni B, Peccini F, et al. Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: a longitudinal study. Clin Exp Allergy 2007; 37:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/61\">",
"      Simola M, Holopainene E, Malmberg H. Changes in skin and nasal sensitivity to allergens and the course of rhinitis; a long-term follow-up study. Ann Allergy Asthma Immunol 1999; 82:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/62\">",
"      Kong W, Chen J, Wang Y, et al. A population-based 5-year follow-up of allergic rhinitis in Chinese children. Am J Rhinol Allergy 2012; 26:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/63\">",
"      Kurukulaaratchy RJ, Karmaus W, Arshad SH. Sex and atopy influences on the natural history of rhinitis. Curr Opin Allergy Clin Immunol 2012; 12:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/64\">",
"      Yonekura S, Okamoto Y, Horiguchi S, et al. Effects of aging on the natural history of seasonal allergic rhinitis in middle-aged subjects in South chiba, Japan. Int Arch Allergy Immunol 2012; 157:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/65\">",
"      Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet 2011; 378:2112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/66\">",
"      Keil T, Bockelbrink A, Reich A, et al. The natural history of allergic rhinitis in childhood. Pediatr Allergy Immunol 2010; 21:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/67\">",
"      Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 2000; 106:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/68\">",
"      Osur SL. Viral respiratory infections in association with asthma and sinusitis: a review. Ann Allergy Asthma Immunol 2002; 89:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/69\">",
"      Spector SL, Bernstein IL, Li JT, et al. Parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol 1998; 102:S107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/70\">",
"      Berman SZ, Mathison DA, Stevenson DD, et al. Maxillary sinusitis and bronchial asthma: correlation of roentgenograms, cultures, and thermograms. J Allergy Clin Immunol 1974; 53:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/71\">",
"      McColley SA, Carroll JL, Curtis S, et al. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997; 111:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/72\">",
"      Craig TJ, Teets S, Lehman EB, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 1998; 101:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/73\">",
"      Rappai M, Collop N, Kemp S, deShazo R. The nose and sleep-disordered breathing: what we know and what we do not know. Chest 2003; 124:2309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/74\">",
"      Alkhalil M, Lockey R. Pediatric obstructive sleep apnea syndrome (OSAS) for the allergist: update on the assessment and management. Ann Allergy Asthma Immunol 2011; 107:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/75\">",
"      Ku M, Silverman B, Prifti N, et al. Prevalence of migraine headaches in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2006; 97:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/76\">",
"      Wight RG, Jones AS, Beckingham E, et al. A double blind comparison of intranasal budesonide 400 micrograms and 800 micrograms in perennial rhinitis. Clin Otolaryngol Allied Sci 1992; 17:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/77\">",
"      Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 2001; 86:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/78\">",
"      Szeinbach SL, Williams PB, Kucukarslan S, Elhefni H. Influence of patient care provider on patient health outcomes in allergic rhinitis. Ann Allergy Asthma Immunol 2005; 95:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/79\">",
"      Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011; 127:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/80\">",
"      Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2012; 67:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/81\">",
"      Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008; 100:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/82\">",
"      Duran-Tauleria E, Vignati G, Guedan MJ, Petersson CJ. The utility of specific immunoglobulin E measurements in primary care. Allergy 2004; 59 Suppl 78:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/83\">",
"      Mansfield L, Hutteman HR, Tyson S, Enriquez A. A multiallergen and miniscreen can change primary care provider diagnosis and treatment of rhinitis. Am J Rhinol Allergy 2012; 26:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/84\">",
"      Ahlstedt S, Murray CS. In vitro diagnosis of allergy: how to interpret IgE antibody results in clinical practice. Prim Care Respir J 2006; 15:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/85\">",
"      Kwong KY, Eghrari-Sabet JS, Mendoza GR, et al. The benefits of specific immunoglobulin E testing in the primary care setting. Am J Manag Care 2011; 17 Suppl 17:S447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/86\">",
"      Measurement of specific and nonspecific IgG4 levels as diagnostic and prognostic tests for clinical allergy. AAAI Board of Directors. J Allergy Clin Immunol 1995; 95:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/87\">",
"      White P, Smith H, Baker N, et al. Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 1998; 28:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/88\">",
"      Harmsen L, Nolte H, Backer V. The effect of generalist and specialist care on quality of life in asthma patients with and without allergic rhinitis. Int Arch Allergy Immunol 2010; 152:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/89\">",
"      Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/90\">",
"      Settipane RA. Rhinitis: a dose of epidemiological reality. Allergy Asthma Proc 2003; 24:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/91\">",
"      Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol 2006; 16:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/92\">",
"      Pass&agrave;li D, Salerni L, Pass&agrave;li GC, et al. Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use. Expert Opin Drug Saf 2006; 5:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/93\">",
"      Graf P. Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med 2005; 4:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/53/22362/abstract/94\">",
"      van Rijswijk JB, Blom HM, Fokkens WJ. Idiopathic rhinitis, the ongoing quest. Allergy 2005; 60:1471.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7525 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-83.177.194.223-190351C039-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22362=[""].join("\n");
var outline_f21_53_22362=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H896753\">",
"      INTRODUCTION AND TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H897169\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H897183\">",
"      Economic burden",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H897849\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H897856\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H897864\">",
"      Signs and symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7950367\">",
"      - Quality of life and cognitive function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7949595\">",
"      - Patterns of symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7950557\">",
"      - Increasing sensitivity over time",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7950204\">",
"      Physical findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7950282\">",
"      Routine laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3324263\">",
"      Natural history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H897892\">",
"      ASSOCIATED CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H514441\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Allergen-specific testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15264438\">",
"      - Skin testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Serum tests for allergy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5649703\">",
"      - Suggestive history with negative testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7949995\">",
"      Uncommonly used tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9486750\">",
"      - Nasal cytology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9486757\">",
"      - Allergen challenge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H905774\">",
"      Unproven diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3018812\">",
"      WHEN TO REFER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3645244\">",
"      Children under two years of age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3645251\">",
"      Older children and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/7525\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/7525|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/61/27615\" title=\"figure 1\">",
"      Peak pollen periods US",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/7525|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/39/23152\" title=\"picture 1\">",
"      Allergic child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/20/14670\" title=\"picture 2\">",
"      Acute seasonal conjunctivitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/7525|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/47/29435\" title=\"table 1\">",
"      Classification of allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/29/476\" title=\"table 2\">",
"      Dx and initial assessment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=related_link\">",
"      Acute bacterial rhinosinusitis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/15/2297?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/2/34856?source=related_link\">",
"      Allergic conjunctivitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39944?source=related_link\">",
"      Aspirin exacerbated respiratory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/5/18519?source=related_link\">",
"      Atrophic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/25/26010?source=related_link\">",
"      Chronic asthma in children younger than 12 years: Evaluation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=related_link\">",
"      Chronic nonallergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=related_link\">",
"      Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11082?source=related_link\">",
"      Clinical manifestations and diagnosis of oral allergy syndrome (pollen-food allergy syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/63/26616?source=related_link\">",
"      Clinical manifestations of relapsing polychondritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=related_link\">",
"      Diagnosis of asthma in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/51/34616?source=related_link\">",
"      Epidemiology and clinical manifestations of invasive aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19653?source=related_link\">",
"      Epidemiology of asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/36/8775?source=related_link\">",
"      Fungal rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/43/19129?source=related_link\">",
"      Increasing prevalence of asthma and allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37430?source=related_link\">",
"      Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/48/7945?source=related_link\">",
"      Occupational rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/22/44391?source=related_link\">",
"      Overview of in vitro allergy tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32633?source=related_link\">",
"      Overview of skin testing for allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6775?source=related_link\">",
"      Pathogenesis of allergic rhinitis (rhinosinusitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/8/41092?source=related_link\">",
"      Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/24/42370?source=related_link\">",
"      Patient information: Allergy skin testing (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/38/37474?source=related_link\">",
"      Patient information: Seasonal allergies in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/10/13475?source=related_link\">",
"      Patient information: Seasonal allergies in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37834?source=related_link\">",
"      Pharmacotherapy of allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/18/20776?source=related_link\">",
"      Relationships between rhinosinusitis and asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32340?source=related_link\">",
"      Respiratory tract changes during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/55/24440?source=related_link\">",
"      The common cold in adults: Diagnosis and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11194?source=related_link\">",
"      The pediatric physical examination: HEENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/22/30056?source=related_link\">",
"      The relationship between IgE and allergic disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_53_22363="Clinical features of MS";
var content_f21_53_22363=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F63940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F63940&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical features of multiple sclerosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Features suggestive of multiple sclerosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Relapses and remissions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Onset between ages 15 and 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Optic neuritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lhermitte's sign",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Internuclear ophthalmoplegia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fatigue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uhthoff's phenomenon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Features not suggestive of multiple sclerosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Steady progression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Onset before age 10 or after age 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cortical deficits such as aphasia, apraxia, alexia, neglect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rigidity, sustained dystonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Convulsions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Early dementia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Deficit developing within minutes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22363=[""].join("\n");
var outline_f21_53_22363=null;
var title_f21_53_22364="Accel phase CML criteria";
var content_f21_53_22364=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria: accelerated phase of chronic myelogenous leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        MD Anderson*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sokal et al&bull;",
"       </td>",
"       <td class=\"subtitle1\">",
"        WHO&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         PB blasts &ge;15 percent",
"        </p>",
"        <p>",
"         PB blasts + pro &ge;30 percent",
"        </p>",
"       </td>",
"       <td>",
"        PB or BM blasts &ge;5 percent",
"       </td>",
"       <td>",
"        PB or BM blasts 10-19 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PB baso &ge;20 percent",
"       </td>",
"       <td>",
"        PB basophils &ge;20 percent",
"       </td>",
"       <td>",
"        PB basophils &ge;20 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Platelets &lt;100,000/&micro;L not related to",
"therapy",
"       </td>",
"       <td>",
"        Thrombocytopenia, not related to therapy",
"       </td>",
"       <td>",
"        Platelets &lt;100,000/&micro;L, unrelated to",
"therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"8\">",
"        Cytogenetic evolution",
"       </td>",
"       <td>",
"        Cytogenetic evolution",
"       </td>",
"       <td>",
"        Cytogenetic evolution",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Platelets &gt;1 million/&micro;L despite",
"adequate therapy",
"       </td>",
"       <td>",
"        Platelets &gt;1,000,000/&micro;L unresponsive",
"to therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marrow collagen fibrosis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anemia, unrelated to Rx",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Progressive splenomegaly",
"       </td>",
"       <td>",
"        Progressive splenomegaly and increasing WBC",
"unresponsive to therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        WBC doubling time &lt;5 days",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unexplained fever",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pelger-Huett-like neutrophils, nucleated RBCs,",
"megakaryocyte fragments",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     WHO: World Health Organization; PB: peripheral blood; BM: bone marrow; pro: promyelocytes; baso: basophils; WBC: white blood cell count; RBC: red blood cells.",
"     <br>",
"      * Kantarjian, HM, et al. Cancer 1988; 61:1441.",
"      <br>",
"       &bull; Sokal, JE, et al. Semin Hematol 1988; 25:49.",
"       <br>",
"        &Delta; Vardiman, JW, et al. Blood 2002; 100:2292.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     For each of the three sets of criteria, the accelerated phase of chronic myelogenous leukemia is diagnosed if one or more of the listed features is present. Adapted from O'Dwyer, ME, et al. Blood 2002; 100:1628.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22364=[""].join("\n");
var outline_f21_53_22364=null;
var title_f21_53_22365="Genesis beta thalassemia";
var content_f21_53_22365=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F73084&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F73084&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 527px\">",
"   <div class=\"ttl\">",
"    Genesis of a beta(0) thalassemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 507px; height: 228px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this patient with beta(0) thalassemia, mutation of a single base in the 39th codon (C&rarr;U), changed its triplet code from CAG (glycine) to UAG (stop), resulting in the production of a stop codon, preventing further extension of the growing beta chain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Takeshita, K, Forget, BG, Scarpa, A Benz, EJ, Jr. Intranuclear defects in Beta-globin mRNA accumulation due to a premature translation termination codon. Blood 1984; 64:13. Copyright &copy; 1984 American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22365=[""].join("\n");
var outline_f21_53_22365=null;
var title_f21_53_22366="Dose response PEG rHuMGDF A";
var content_f21_53_22366=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F59564&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F59564&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Response to thrombopoietin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 439px; height: 303px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dose-response of daily subcutaneous injections of PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) for 28 days on the peripheral platelet count in baboons. The daily doses were 0.05 (red), 0.10 (blue), 0.50 (black), and 2.50 (green) &micro;g/kg. The peripheral platelet count increased incrementally in a log-linear dose-response manner.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Harker, LA, Marzec, UM, Hunt, P, et al, Blood 1996; 88:511.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22366=[""].join("\n");
var outline_f21_53_22366=null;
var title_f21_53_22367="Adult with SWS and port wine stain";
var content_f21_53_22367=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58831&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Port wine stain affecting an adult with Sturge-Weber syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 248px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The appearance of the facial port wine stain changes with age. In the newborn, the lesion is flat and usually light pink in color. It typically darkens with age to a deep red, port wine appearance, and vascular ectasias develop as depicted above.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John Bodensteiner, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_53_22367=[""].join("\n");
var outline_f21_53_22367=null;
